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Abstract 
 
Matthew C. LaFave: Detection and Analysis of Common Fragile Sites in Drosophila 
melanogaster 
(Under the direction of Jeff Sekelsky) 
 
Common fragile sites (CFSs) are regions of DNA exceptionally prone to breakage.  
While these regions have implications in cancer, the causes of chromosome fragility remain 
poorly understood.  This is partially due to relatively low-resolution cytological mapping of 
CFSs, and the use of exogenous agents to induce chromosome breakage.  In an effort to better 
understand the causes of fragility, I have developed Drosophila melanogaster as a model for CFS 
study.  In doing so, I have developed approaches to identify CFSs at a high resolution, based on 
both spontaneous chromosomal events and breakage induced by the inhibition of replication.  In 
the first approach, I used a mutant form of mus309, the ortholog of human BLM helicase, to 
locate CFSs by visualizing sites of DNA breakage as mitotic crossovers.  High rates of breakage 
correspond to CFSs, and results from my study indicate that there is a significantly non-uniform 
rate of mitotic crossovers across the left arm of chromosome 2.  This work constitutes the first 
report of specific regions sensitive to endogenous damage in D. melanogaster.  Further, the 
resolution of damage detection can be brought even higher with SNP mapping.  My second 
approach is a novel assay that uses S2 cell culture to detect preferential sites of exogenous DNA 
integration, a hallmark of CFSs.  This allows me to survey the entire genome, while using high-
throughput sequencing to obtain a resolution of CFS detection orders of magnitude better than 
previous studies.  I obtained numerous integration events under a variety of conditions, providing 
evidence of putative fragile regions.  I anticipate that the assays I developed will serve as valuable 
tools for the detection of DNA breakage in future studies.  Further, I expect the characterization 
iv 
of the CFSs detected from both of these approaches will lead to a better understanding of the 
causes of inherent genome instability.   
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Chapter I 
General Introduction 
 
Genome stability & fragile sites 
DNA serves as the master plan for the cell, encoding the information for processes 
necessary to begin and sustain life.  Just as the information encoded by the genome is important, 
the physical integrity of the DNA is critical to ensure successful implementation of the coded 
information.  When genome stability is compromised, the negative effects on the cell or organism 
can be varied and severe (DILLON et al. 2010).  It is critical, therefore, for the cell to maintain the 
integrity of its genome.  The cell has evolved numerous mechanisms to cope with this issue 
(SANCAR et al. 2004).  However, damage can occur, and often does.  Damage can come from 
exogenous sources, such as UV radiation or chemicals, or endogenous sources, such as 
byproducts of cellular metabolism or errors during DNA replication (DE BONT and VAN 
LAREBEKE 2004).  Interestingly, some regions of DNA appear to be more prone to damage than 
others. 
 
Rare fragile sites 
Regions of DNA that are exceptionally prone to chromosomal abnormalities – chiefly 
breakage – have been termed “fragile sites” (DURKIN and GLOVER 2007).  When a fragile site 
forms a break or gap, it is said to be expressed.  Fragile sites have two classifications: rare and 
common.  Rare fragile sites (RFSs) are found infrequently in the human population, and are 
associated with specific disease alleles (SUTHERLAND et al. 1998).   Most RFSs are folate-
sensitive, meaning that they express their fragile characteristics in cells cultured in folate-
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deficient media (LUKUSA and FRYNS 2008).  The few RFSs that are not folate-sensitive have their 
expression induced by bromodeoxyuridine (BrdU) and/or distamycin A, agents that integrate into 
DNA and interfere with replication (LUKUSA and FRYNS 2008).   
RFS only exhibit fragility in an individual with the disease.  For example, the cultured 
cells of an individual with Fragile X disease would exhibit a chromosome constriction at the 
FRAXA RFS, whereas those of a healthy individual would not (MCBRIDE 1979; VERKERK et al. 
1991).  The causes of RFS fragility are relatively well understood: the expansion of di- or 
trinucleotide repeats leads to non-B DNA structures, which interfere with DNA replication and 
nucleosome assembly.  The wild type copy number of such repeats is tolerated by the cell, but 
expansion beyond a threshold value specific to each RFS leads to chromosomal instability 
(LUKUSA and FRYNS 2008).  The increased prevalence of non-B DNA makes these regions prone 
to DNA gaps and breaks (FREUDENREICH 2005). 
 
Common fragile sites 
Common fragile sites (CFSs), on the other hand, are generally considered to be a normal 
component of chromosome structure.  There have been 88 CFSs identified in the human genome, 
thirteen of which have been characterized at a resolution higher than that of chromosome bands 
(LUKUSA and FRYNS 2008).  CFSs are presumed to be ubiquitous in the human population, 
although some studies have indicated variability in the fragility of sites between individuals, and 
between different tissues (DENISON et al. 2003; TEDESCHI et al. 1992).  In addition, CFSs are not 
all equally fragile; the first study of CFSs found that, in humans, 80% of breaks at CFSs were due 
to only 20 CFSs (GLOVER et al. 1984).  The CFSs FRA3B and FRA16D are the most highly 
expressed.  
Human CFSs have a medically relevant connection to cancer.  When expressed in the 
presence of aphidicolin, CFSs have been shown to serve as significant predictor of breast, 
ovarian, and lung cancer (DHILLON et al. 2003).  Breaks at CFSs are associated with genomic 
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rearrangements implicated in cancer, including loss of heterozygosity (DURKIN and GLOVER 
2007).  Recurrent breaks at CFSs have been found in prostate, breast, lung, and pancreatic cancer, 
among many other types (CARTER et al. 1990; CHEN et al. 1996; HIBI et al. 1992; NEGRINI et al. 
1996; SHRIDHAR et al. 1996).  In fact, most cancer-specific translocations have at least one 
breakpoint in a fragile site (BURROW et al. 2009).  Furthermore, the human CFSs most prone to 
breakage, FRA3B and FRA16D, lie within tumor suppressor genes (HUEBNER and CROCE 2003; 
O'KEEFE and RICHARDS 2006).  This indicates that breaks in these regions, especially if they are 
repaired incorrectly or go unrepaired, could contribute to downstream events involved in 
tumorigenesis.  Indeed, breaks at CFSs have been shown to be capable of initiating gene 
amplification via breakage-fusion bridge cycles (COQUELLE et al. 1997).   
The strict definition of what constitutes a CFS comes from the way they are traditionally 
detected.  CFSs are defined as choromsomal regions that form reproducible breaks on metaphase 
chromosomes after partial inhibition of DNA replication (DURKIN and GLOVER 2007).  Breaks 
can be observed in cells grown in folate-deficient media or in the presence of fluorodeoxyuridine, 
although the level of breakage is low (GLOVER 1981; YUNIS and SORENG 1984).  Efficient 
inhibition of replication is therefore usually achieved by use of aphidicolin, and occasionally by 
agents such as BrdU or 5-azacytidine (GLOVER et al. 1984; SUTHERLAND et al. 1985).  
Aphidicolin acts to inhibit polymerases involved in DNA replication, such as polymerase α, δ, 
and ε (CHENG and KUCHTA 1993; GOSCIN and BYRNES 1982; IKEGAMI et al. 1978).  While 
aphidicolin can be used to completely halt the cell cycle in S phase, CFSs are induced using a low 
concentration of the agent, typically 0.4 µM (GLOVER et al. 1984).  At this concentration, 
aphidicolin makes the replication of DNA somewhat more difficult, without causing it to stop 
altogether.   
It has been observed that down-regulation of components of homologous recombination, 
such as RAD51, or of non-homologous end joining, such as DNA-PKcs, results in a significant 
increase in CFS expression in cells treated with aphidicolin (SCHWARTZ et al. 2005).  This 
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indicates that expressed CFSs can be repaired both by homologous repair and non-homologous 
end-joining.  CFSs have been reported to be prone to sister chromatid exchanges after treatment 
with aphidicolin, a result of homologous repair of the double-strand break (DSB) incurred at the 
CFS (GLOVER and STEIN 1987; HIRSCH 1991).  Of course, not all expressed CFSs are repaired 
after exposure to replicative stress, leading to the characteristic breaks on metaphase 
chromosomes. 
 
CFSs appear to be evolutionarily conserved 
An interesting, and somewhat counter-intuitive, characteristic of CFSs is that they appear 
to be evolutionarily conserved.  Most studies of CFSs are done with human chromosomes, but 
CFSs have also been detected in several other mammals.  It has been shown that mice have CFSs 
that correspond to known human CFSs (HELMRICH et al. 2006; HELMRICH et al. 2007).  These 
studies in mice showed conservation of specific CFSs, but regions analogous to CFSs – that is, 
regions prone to breakage, especially when under replicative stress – have also been detected in 
yeast.   
Reducing levels of polymerase α in Saccharomyces cerevisiae has been shown to 
increase the rate of breaks leading to translocations, due in large part to retrotransposons called 
Ty elements (LEMOINE et al. 2005).  A site at which Ty elements formed an inverted repeat was 
found to be prone to double-strand breaks under these conditions; therefore, it has the 
characteristics of a CFS.  A separate study found that a region containing tRNA genes was prone 
to DNA breaks (ADMIRE et al. 2006).  Disruption of replication by exogenous agents or mutation 
of a helicase resulted in increased instability in this region, and removal of the region reduced the 
overall genomic instability of the cell.  Finally, a study of spontaneous mitotic recombination in 
yeast identified a 1.3 kb region that was significantly more prone to crossovers than surrounding 
regions (LEE et al. 2009).  We published a Perspectives article on this work, in which we pointed 
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out that such a region might constitute a CFS prone to endogenous damage (LAFAVE and 
SEKELSKY 2009).   
  
Proposed causes of CFS fragility 
It is important to note that the reasons CFSs are prone to damage are not well understood.  
CFSs do not appear to share the nucleotide repeats characteristic of RFSs, so the reason for CFS 
fragility is likely to be somewhat different (ARLT et al. 2002; RASSOOL et al. 1996; SCHWARTZ et 
al. 2006).  CFSs can be induced by agents that interfere with replication, so it is generally thought 
that some aspect of fragile regions that make them inherently difficult to replicate.   
This claim is bolstered by genetic evidence, which involves the checkpoint kinase 
Ataxia-telengiectasia and Rad3 Related (ATR).  This protein is involved in signaling the response 
to stalled or collapsed replication forks, as well as the response to single stranded DNA exposed 
by damage.  In human cell culture, ATR has been shown to be necessary for CFS stability 
(CASPER et al. 2002).  CFS expression is enhanced in the presence of aphidicolin in ATR mutant 
cells, and such cells spontaneously express CFSs even in the absence of aphidicolin.  ATR has 
been found to preferentially interact with FRA3B after treatment with aphidicolin (WAN et al. 
2010).  Depletion of CHK1, the downstream effector of ATR, also results in CFS expression 
(DURKIN et al. 2006).  Similar results have been reported in yeast, in which cells mutant for the 
ortholog of ATR, Mec1, display an increase in DNA breaks in replication slow zones (CHA and 
KLECKNER 2002).  These reports suggest that a key early step in CFS expression is the stalling of 
a replication fork, consistent with the notion that CFSs are inherently difficult to replicate.  What 
causes the forks to stall, however, remains an open question.  Here, I discuss some of the major 
properties that have been proposed to contribute to CFS fragility. 
 
6 
Primary sequence characteristics 
Many characteristics of CFSs have been proposed as the reasons for their fragility.  
Primary sequence attributes have received a considerable amount of attention in this regard.  One 
model posits that aphidicolin causes uncoupling of polymerases from the helicase-topoisomerase 
complex at the replication fork, resulting in exposed single stranded DNA (ssDNA) (DURKIN and 
GLOVER 2007).  Some of the sequences in CFSs have the potential to form stable secondary 
structures – therefore, exposure of such sequences as ssDNA may lead to hairpins and other 
structures that disrupt replication.  Interestingly, the breaks and ssDNA at CFSs can be reduced 
by low-dose camptothecin, even in the presence of aphidicolin (ARLT and GLOVER 2010).  It is 
thought that low concentrations of camptothecin may slow the helicase-topoisomerase complex, 
and that this may reduce the polymerase uncoupling normally induced by aphidicolin. 
No sequence motifs have been detected in CFSs, although it is unclear if the relatively 
low resolution of CFS detection makes such regions difficult to identify (MISHMAR et al. 1998; 
SCHWARTZ et al. 2006).  Still, there is evidence that the sequence of CFSs is inherently unstable.  
It was shown in a study in which bacterial artificial chromosomes (BACs) carrying sequence 
from FRA3B were inserted at ectopic sites of the human genome that the FRA3B BACs could 
recapitulate fragility, while control BACs did not (RAGLAND et al. 2008).   
In addition, DNA flexibility has been proposed to be a major cause of CFS fragility 
(SCHWARTZ et al. 2006).  Flexibility calculations are based on the maximum potential angular 
twist that two consecutive bases could achieve (SARAI et al. 1989).   A program, TwistFlex, was 
developed to calculate the average potential twist of DNA in a sliding window; averages that 
surpass a threshold value are reported as flexibility peaks (MISHMAR et al. 1998).  Several CFSs 
have been analyzed in this way, and found to have a high number of flexibility peaks (DURKIN 
and GLOVER 2007).  Interestingly, a highly flexible region of human FRA16D inserted into the S. 
cerevisiae genome was shown to induce fragility, while non-flexible regions did not (ZHANG and 
FREUDENREICH 2007).  The reported flexibility of such regions is likely a result of the AT-rich 
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nature of CFSs, as the A to T step is more than twice as flexible as any other possible step (SARAI 
et al. 1989).  These regions could contribute to fragility via secondary structure formed by AT 
repeats.  However, if DNA flexibility is involved in CFS fragility, it is unlikely to be the sole 
cause.  Not all CFSs have more flexibility peaks than controls, and BACs with a high number of 
flexibility peaks are not sufficient to recapitulate fragility in ectopic regions (HELMRICH et al. 
2007; RAGLAND et al. 2008). 
 
Chromatin environment 
The state of the chromatin surrounding CFSs has also been considered to contribute to 
fragility.  Though not strictly related to replication problems caused by aphidicolin, the banding 
pattern of metaphase chromosomes has raised an interesting issue regarding fragility.  The dark 
G-bands tend to be AT-rich, late replicating, and have few genes; the light R-bands are just the 
opposite: early-replicating and gene- and GC-rich (GARDINER 1995).  Some CFSs, including 
FRA3B, have the characteristics of the dark G-bands, but map to R-bands.  It has been suggested 
that CFS fragility may be related to the discrepancy between the chromatin context of CFSs and 
their surrounding environment (SCHWARTZ et al. 2006).  Others have suggested that histone 
modifications may play a role in fragility.  Histones at CFSs have been found to be 
hypoacetylated, and FRA3B is more resistant to micrococcal nuclease than nearby non-fragile 
regions (JIANG et al. 2009).  These findings suggest that CFS chromatin might be more compact 
than flanking regions, and raise questions about the role of chromatin in fragility. 
 
Replication timing & origin density 
The timing of replication, and the related factor of the distance from a firing replication 
origin, may have a substantial impact on fragility.  CFSs are often associated with large, late-
replicating genes in humans (LE BEAU et al. 1998).   It has been reasoned that these regions are 
fragile because they are unable to replicate their DNA by the end of S phase, especially in the 
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presence of replication-inhibiting aphidicolin.  FRA16D, for example, was found to have a slow-
moving replication fork (PALAKODETI et al. 2004).  Recently, it was determined that the center of 
FRA3B is origin-poor in JEFF lymphocytes (LETESSIER et al. 2011).  Moreover, in cells in which 
FRA3B was not origin-poor, such as MRC-5 fibroblasts, fragility was not observed.  This 
suggests that the combination of replication timing and origin density play a major role in CFS 
fragility, and may explain tissue-specific differences in CFS expression.  However, studies that 
have found that insertions of CFS DNA in ectopic regions are sufficient to recapitulate fragility, 
while control insertions are not, suggest that origin density is insufficient to fully explain fragility 
(RAGLAND et al. 2008; ZHANG and FREUDENREICH 2007). 
 
Issues of resolution 
While much has been learned about the characteristics of CFSs, studies of CFSs have 
suffered from the use of relatively low-resolution approaches.  The initial mapping of CFSs were 
accomplished by observing breaks on metaphase chromosome spreads, and were thus limited to 
the resolution of chromosome bands (GLOVER et al. 1984).  Fluorescent in situ hybridization 
probes have been used to achieve a somewhat higher resolution (BECKER et al. 2002).  These 
studies score breaks qualitatively – proximal, distal, or within – relative to a probe of known 
location.  By doing this for many probes, a distribution of breaks can be generated.  This 
technique is good for determining the outer boundaries of fragility and general shape of the 
distribution, but the effective resolution is still in the hundreds of kilobases.  This is because the 
precise location of any given break cannot be inferred from its position relative to a probe.  
Because of this, CFSs have been classified as large, fragile regions, often a megabase or more in 
length (BECKER et al. 2002; HANDT et al. 2000). 
This resolution makes it difficult to ascertain which factors truly contribute to fragility.  
For example, it leaves us unable to distinguish between a single large region of fragility, and 
several smaller regions of fragility that cluster together.  To answer the question of the nature of 
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fragility, it would be advantageous to focus on what I will refer to as the minimal fragile region – 
the most fragile portion of the CFS.  Including in the analysis regions that are less fragile may 
have the effect of drowning out the truly relevant information from the minimal fragile region.   
 
Induced vs. natural CFSs  
Almost all of what we know about CFSs is based on damage induced by exogenous 
sources, typically aphidicolin.  The use of such inducers of fragility has been necessitated by the 
difficulty of locating sites of endogenous damage in human cell culture.  The physiological 
relevance of these aphidicolin-induced regions is well-established; the most fragile CFSs, such as 
FRA3B and FRA16D, have been implicated in recurrent tumorigenic breakpoints (HUEBNER and 
CROCE 2003; O'KEEFE and RICHARDS 2006).  Still, I felt it would be useful to determine the 
location of CFS breaks caused by endogenous lesions.  This constitutes DNA damage that the 
genome normally incurs, but typically repairs in a way that makes the initial break difficult to 
detect.   I designed assays in a way that allowed me to examine damage incurred under both types 
of conditions.  I will refer to CFSs corresponding to endogenous breaks as “natural CFSs”; those 
that have their fragility induced by exogenous sources will be referred to as “induced CFSs”.  By 
analyzing both types of regions, one can determine if induced CFSs are exceptionally aphidicolin-
sensitive, or if aphidicolin simply increases the expression of natural CFSs.  
 
Using Drosophila to study CFSs 
To accomplish the tasks of studying CFSs at a high-resolution, induced by endogenous or 
exogenous means, I chose to work with Drosophila melanogaster.  To my knowledge, there have 
been no previous studies to detect CFSs in Drosophila.  Most studies of CFSs have taken place in 
human cell culture, and a few have used yeast; this study gives me an opportunity to develop D. 
melanogaster as the first live, whole-organism in vivo metazoan model of CFSs.  There exists an 
extensive genetic toolkit for Drosophila, with many useful mutations available, not the least of 
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which is a mutation that greatly increases the frequency of mitotic crossovers (MCVEY et al. 
2007).  My implementation of an assay that takes advantage of the characteristics of this mutant 
to detect endogenous damage and verify the presence of CFSs in D. melanogaster is detailed in 
Chapter II.  This is the first report of CFSs detected in Drosophila.  Having established the 
presence of such sites, I developed a cell-based assay that couples selectable DNA integration 
with high-throughput sequencing (HTS) to identify putative CFSs at a high resolution, and on a 
genome-wide scale.  The assay, as well as my analysis of the integration sites, is detailed in 
Chapter III.  I have analyzed the results of these assays to offer insight into the nature of fragility. 
 
 
 
 
 
Chapter II 
Common Fragile Sites and Mitotic Crossovers 
 
Introduction 
Common fragile sites (CFSs) are chromosomal regions that are prone to breakage, 
particularly when under DNA replication stress.  While the existence and location of human CFSs 
are well-documented (DURKIN and GLOVER 2007), the relatively low resolution at which CFSs 
have been studied means that an understanding of the causes of fragility has remained elusive.  I 
aimed to determine the causes of fragility by employing high-resolution approaches in 
Drosophila melanogaster.  By increasing the resolution at which CFSs are detected and analyzed, 
we increase the chance of determining features unique to CFSs.  In addition, it permits one to 
distinguish between a CFS as a single, large region of fragility, or several smaller regions 
clustered close together. 
This study established D. melanogaster as a metazoan in vivo model of CFSs.  This 
particular combination has not been available to the CFS field before – studies are typically 
carried out in human cell culture (GLOVER et al. 1984), and occasionally in sacrificed mice 
(HELMRICH et al. 2006).  So far, the only truly in vivo studies of CFSs have been in budding yeast 
(ADMIRE et al. 2006; LEMOINE et al. 2005).  Working in Drosophila allows us to bridge studies 
in yeast and mammals, and to ask questions about the evolutionary conservation of CFSs. 
The first step was to determine the location of D. melanogaster CFSs – indeed, to see if 
flies have CFSs at all.  Data in yeast, as well non-human mammals such as mice, dogs, and cats, 
suggest that such regions are conserved (HELMRICH et al. 2007; LEMOINE et al. 2005; STONE et 
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al. 1991; STONE et al. 1993).  However, no one had looked for CFSs in Drosophila, and so 
detection of the sites became my primary task. 
I chose to use a novel genetic assay to determine the presence and location of CFSs (Fig. 
2.1).  My assay allowed me to map sites of DNA breakage by taking advantage of a characteristic 
of flies mutant for mus309, which encodes Drosophila BLM (DmBLM).  DmBLM is the 
Drosophila homolog of human BLM, a RecQ helicase (ADAMS et al. 2003; BACHRATI and 
HICKSON 2003).  Humans that lack BLM have Bloom’s Syndrome (BS), characterized by short 
stature, sterility, sensitivity to sunlight, and increased susceptibility to a broad spectrum of 
cancers.  This last phenotype underscores the role of BLM as a fundamental protein in DNA 
repair.  BS cells display an increased rate of sister chromatid exchanges (CHAGANTI et al. 1974).  
BLM can act on structures formed during homologous repair, such as migrating Holliday 
junctions and unwinding D-loops in vitro (KAROW et al. 2000).  BLM also acts to maintain the 
integrity of stalled replication forks (DAVIES et al. 2007; MANKOURI and HICKSON 2007).  In 
Drosophila, there is evidence suggesting that DmBLM acts to free newly-synthesized DNA from 
the template D-loop during homologous repair (MCVEY et al. 2004).   
The feature of mus309 mutants most relevant to this study is the greatly increased rate of 
mitotic crossovers (MCVEY et al. 2007).  Such crossovers are associated with sites of endogenous 
breaks (Fig. 2.1).  In flies with wild type mus309, DNA damage in mitotically dividing cells is 
typically repaired to yield a non-crossover product.  Mitotic crossover frequencies in this situation 
are typically below 0.002% between dp and bw, a region covering a little under 30% of the 
genome (WOODRUFF and THOMPSON 1977).  In flies homozygous mutant for mus309, however, 
mitotic crossover frequencies are about 2% between st and e, a region that covers a little over 
20% of the genome (MCVEY et al. 2007).  I designed an assay in which these crossovers would 
occur in the male germline, so the location of the crossover – and therefore the initial site of 
endogenous damage – could be detected via mapping of recessive markers in the progeny of the 
male. 
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A key feature of the assay is that it allows one to map breaks incurred from endogenous 
sources.  Although such damage, which cells normally incur, is the most biologically relevant, 
most studies of CFSs have focused on damage induced in the presence of exogenous agents, 
usually aphidicolin (DURKIN and GLOVER 2007).  This is because endogenous damage normally 
occurs at a frequency that is difficult to detect with traditional, cytology-based approaches to 
mapping CFSs (GLOVER et al. 1984).  My assay detects endogenous damage at a sufficiently high 
frequency to make the analysis of such damage straightforward.  This permits me to determine 
the location of natural CFSs. 
In addition, the assay can be modified to detect breakage in the presence of replicative 
stress.  Direct treatment with aphidicolin is possible, but would be impractical – flies would have 
to be fed the chemical, and it would be very difficult to ensure that each fly consumed exactly the 
same dosage.  However, I was able to create a mutant that genetically mimics the effect of 
aphidicolin.  Since aphidicolin acts to inhibit replicative polymerases, I removed one copy of 
DNApol-α180, the gene encoding for the catalytic subunit of polymerase α (LAROCQUE et al. 
Figure 2.1.  Detection of fragile sites.  Genomic damage incurred in mitotic cells of wild-
type flies is repaired to yield a non-crossover product, making the site of damage difficult to 
detect. The mus309 mutant flies lack DmBLM protein, which results in damage being 
repaired to produce a mitotic crossover product.  If this occurs in the male germline, it will 
yield progeny in which the location of the crossover, and therefore the site of damage, can be 
mapped.  The marker genes and P-element used for mapping are represented on the 
chromosomes; the ● indicates the centromere. 
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2007a); DNApol-α180 will henceforth be referred to as Polα).  In this way, the assay can be used 
to detect either endogenous damage, or damage like that induced by aphidicolin. 
The assay is also able to recover both halves of a DNA damage repair event.  This is 
noteworthy, because one typically is only able to recover and examine one half of a mitotic 
crossover in metazoans, limiting the amount of information that can be gleaned from such a 
study.  In my assay, mitotic crossovers occur pre-meiotically in the male germline, meaning that 
both halves of the crossover are produced as gametes.  Analysis of the repair event from 
reciprocal crossover siblings gives us the ability to determine the nature of repair in a mus309 
mutant background. 
I employed this assay to determine if CFSs are present on the left arm of chromosome 2 
in D. melanogaster.  Here, I treat CFSs as regions that are prone to DNA breakage; the source of 
this damage can be either endogenous or the result of replication inhibition.  My assay allows one 
to distinguish between the two sources of damage, and lends itself to insights regarding the nature 
of chromosome fragility.  I argue that D. melanogaster does contain CFSs, both induced and 
natural, and identify fragile regions on 2L. 
 
Results  
It was first necessary to determine if the fly genome contains regions that are especially 
prone to DNA breakage.  I accomplished this through the use of a mitotic crossover assay (Fig. 
2.2).  In these mus309 mutants, sites of DNA breakage can be repaired to produce a mitotic 
crossover.  The crossover is located at the site of initial damage, so by using phenotypic markers 
to map a distribution of crossovers, I was able to essentially generate a visualization of the 
distribution of breakage.  
15 
 
In the first iteration of the assay, I analyzed 532 crossovers from 313 mus309N1 males.  
By examining the distribution of mitotic crossovers on 2L, I was able to determine that the rate of 
crossing over, and therefore the rate of endogenous damage, is significantly non-uniform 
(bootstrapping, P < 0.0001; Fig. 2.3).  This suggests that regions that produced the highest rates 
of crossing over – specifically, the regions between net and dp, and between b and pr – constitute 
CFSs, or that they contain more CFSs than the other intervals.  In release 5 of the D. 
melanogaster genome, these regions cover the regions 2L:87,382..4,479,471 and 
2L:13,823,894..20,073,719, respectively.  These results were recapitulated in additional 
experiments in which stocks with different markers were used to derive the 2nd chromosome 
homologs, and where a different combination of mus309 alleles was used (P = 0.0002; Figs. 2.4 
and 2.5).  In this version of the assay, I analyzed 634 crossovers from 391 mus309N1/mus309D2 
Figure 2.2.  Cross scheme to visualize mitotic crossovers.  Virgin females heterozygous for 
mus309N1 and homozygous for a P element on 2L were crossed to mus309N1 males that 
carried a 2nd chromosome with six recessive phenotypic markers (Cross 1).  From the progeny 
of this cross, males that did not carry TM6B, and were therefore homozygous for mus309N1, 
were collected.  These flies carried one copy of each of the parental chromosomes, and the 
crossovers I was able to analyze in the following generation were produced in the pre-meiotic 
germline of these males.  Each male was crossed to three virgin females homozygous for the 
marker chromosome (Cross 2).  The progeny of this cross were scored for mitotic crossovers.  
One or both halves of the crossover could be recovered, and the P element could be detected 
via PCR to serve as an additional marker.  The ● indicates the centromere. 
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males.  The heteroallelic combination of mus309 alleles demonstrates that the crossovers detected 
in the assay are due to the lack of functional DmBLM, and not to homozygous second-site 
mutations.  The al-dp fragile region detected in this version of the assay covers the region 2L: 
387,439..4,479,471. 
 
Figure 2.3.  The rate of crossovers is non-uniform.  Five phenotypic markers on 2L (net-
pr) and one on 2R (cn) were used to determine the rate of mitotic crossovers in the male 
germline.  One homolog of chromosome 2 carried the markers, and the other carried a P 
element to increase the resolution of the 9.2 Mb between dp and b.  PCR was used to detect 
the P element.  Crossover data was collected in vials of three females crossed to a single 
male; each vial therefore represents crossovers in the germline of one male.  The red line 
represents males homozygous mutant for mus309N1 (532 crossovers, 313 vials), while the 
blue line represents males that were both homozygous mutant for mus309N1 and heterozygous 
mutant for DNApol-α180, the gene for Polα (334 crossovers, 157 vials). Dotted lines are the 
average crossover rates over the entire 40.6 Mb interval. The region between pr and cn 
contains about 16.4 Mb of heterochromatin, which is included in the calculation of the 
crossover rate.  
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Figure 2.4.  Cross scheme to visualize and recapitulate mitotic crossovers for future SNP 
sequencing.  The initial steps are as described in Fig. 2.2, with the following relevant 
differences.  Parental virgin females carry the Celera reference sequence chromosome, 
marked with cn bw sp.  Males carry a slightly different marker chromosome, the alleles of 
which facilitate production of a crossover (CO) stock two generations later.  Males also carry 
a different allele of mus309; the heteroallelic arrangement in the following generation 
prevents second-site mutations from affecting the experiment.  COs are again generated in 2nd 
generation males, which are visualized by a cross to three to five marker chromosome virgin 
females (Cross 2).  Again, one or both products of the CO can be recovered; one possible CO 
is shown here.  If the fly in which the CO is visible is a male, the fly is crossed to a stock 
containing the SM6a 2nd chromosome balancer (Cross 3).  The al dp sp markers carried on 
SM6a allows one to distinguish between the CO chromosome and the marker chromosome; in 
this way, balanced CO chromosomes are made into a stock.  Flies from this stock can be 
crossed to marker chromosome flies to recapitulate the genotype of the original crossover fly; 
alternatively, flies from this stock can be crossed to each other to produce flies homozygous 
for the CO (Cross 4). Either type can be frozen in anticipation of future SNP mapping of the 
CO. 
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The mus309 mutant background provides information about the rate of endogenous 
breakage.  While it would be useful to modify this assay – by adding aphidicolin – to obtain 
information about the rate of breakage due to an exogenous source, this would not be practical.  
Instead, I chose to use a genetic means of mimicking exogenous damage.  I introduced replicative 
stress by using one mutant copy of Polα; 334 crossovers were analyzed from 157 mus309N1 
+/mus309N1 Polα males.  By doing so, I found that the rate of mitotic crossing over on 2L was 
again significantly non-uniform (P < 0.0001).  In most regions, the rate was elevated above the 
rate detected in the version of the assay that was designed to detect purely endogenous damage. 
Figure 2.5.  The rate of crossovers is non-uniform in a heteroallelic mus309 background.  
The DmBLM crossover assay was repeated in a different genetic background, as depicted in 
Fig. 2.4.  Crossovers were accrued between a marker chromosome carrying al dp b pr cn, and 
a reference chromosome with cn bw sp.  The crossover rate displayed here only takes into 
account vials in which at least one crossover was detected.  Crossover data was collected in 
vials of three to five females crossed to a single male; each vial therefore represents 
crossovers in the germline of one male.  The solid green line represents males mutant for 
mus309N1/mus309D2 (634 crossovers, 391 vials), and the dotted line is the average crossover 
rates over the entire 19.6 Mb interval. 
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In both cases, the regions between net and dp, and between b and pr, appear to be more prone to 
DNA breakage than the other regions of 2L.  
I found that my assay often produced reciprocal crossovers.  For example, if a crossover 
occurred between b and pr, the following generation might produce both net dppd-ho dp b + + 
flies, as well as their + + + + pr cn siblings.  Since this presented a unique opportunity to learn 
about DNA repair in a mus309 mutant background by examining both products of a crossover, 
reciprocal crossover flies from the second iteration of the assay (the al dp b pr cn version) were 
crossed to produce multiple flies that recapitulated the original crossover (Fig 2.4).  The DNA of 
seven of these flies has been submitted for high-throughput sequencing and SNP mapping. 
 
Discussion 
Non-uniform breakage indicates CFSs 
I undertook this study to determine if D. melanogaster had CFSs, and to identify the 
location of such sites.  To do so, I developed an assay that allowed me to locate sites of 
endogenous double-strand breaks (DSBs) by visualizing these sites as mitotic crossovers.  In 
addition, I have laid a foundation for further studies that are expected to increase the resolution of 
this initial mapping by orders of magnitude. 
I have demonstrated that the rate of mitotic crossing over, and therefore the rate of DNA 
damage repaired by a crossover, is significantly non-uniform on 2L.  This observation holds true 
in all backgrounds tested, and indicates that 2L has regions that are more prone to DSBs than 
other regions.  It is important that similar crossover distributions were observed in genetic 
backgrounds with different 2nd chromosomes, as it shows these damage-sensitive regions to not 
be an isolated phenomenon.  These regions – specifically, net-dp and b-pr – therefore constitute 
CFSs.  This is noteworthy, as this is the first report of CFSs in Drosophila.  The apparent 
evolutionary conservation of CFSs as a feature of chromosomes is consistent with the report of 
regions analogous to induced CFSs in budding yeast (LEMOINE et al. 2005).  Furthermore, the 
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fact that I was able to locate regions prone to endogenous DSBs has important implications for 
our understanding of fragility.   
 
Sources of breaks in the crossover assay 
The natural and induced versions of the assay both detect DSBs associated with 
replication; the difference in the two methods lies in the initial source of the break.  In the assay 
presented here, natural CFSs are regions that incur DSBs in cells that lack DmBLM.  In general, 
endogenous DSBs are likely to be the result of single-strand DNA lesions, such as single-strand 
breaks, apurinic/apyrimidinic sites, and oxidation products (VILENCHIK and KNUDSON 2003).  
Such lesions can be converted to DSBs during DNA replication.  Therefore, regardless of when 
the initiating lesion is acquired, the actual DSB is likely to be produced during S phase.  In the 
context of mus309 mutant cells, lesions that block replication fork progression are likely to be the 
main contributors to endogenous DSBs, because DmBLM likely acts to prevent the collapse of 
stalled forks (DAVIES et al. 2007).  Such fork stalling can result from the presence of an abasic 
site on the leading strand (HIGUCHI et al. 2003).  Without DmBLM to promote fork regression or 
stabilization of the fork, encountering such a lesion could lead to fork collapse and a DSB 
(MANKOURI and HICKSON 2007).  Therefore, DmBLM mutant cells should not have any more 
stalled forks than wild type cells, but the forks that do stall should be much more likely to become 
DSBs.  These DSBs, in turn, are repaired as mitotic crossovers, due to the role of DmBLM in 
preventing crossovers during DSB repair. 
Breaks at induced CFSs, on the other hand, are the result of inhibition of the replicative 
polymerases.  Such inhibition leads to increased ssDNA at the fork and an overall reduction in 
fork speed, and may result in polymerase-helicase uncoupling (ARLT and GLOVER 2010; 
LETESSIER et al. 2011).  These features could lead directly to DSBs; for example, a nick on 
ssDNA would result in a one-ended DSB.  Alternatively, these features, particularly polymerase-
helicase uncoupling, could result in stalling of the replication fork.  In cells with a reduced level 
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of active polymerases but which are wild type in all other respects, such as cells treated with 
aphidicolin, the increased number of stalled forks may exceed the cell’s ability to stabilize them 
all.  This results in increased DSBs.   
In cells with reduced Polα and mutant mus309, the crossovers observed are from breaks 
likely to be due to a combination of these effects.  Polα reduction increases the number of forks 
that stall, and the lack of DmBLM results in a greater percentage of those stalled forks resulting 
in DSBs.  The DSBs are then repaired to produce COs.  The crux of the issue, of course, is where 
the forks stall.  As previous studies have focused on induced CFSs, it was not yet known if the 
regions of fork stalling due to polymerase inhibition are similar to those in which stalling 
normally occurs.  The similarity of the natural and induced damage distributions detected by my 
crossover assay implies that fork stalling occurs at the same sites regardless of the state of 
replication inhibition. 
  
Implications of replication inhibition and endogenous breaks  
The distribution obtained from flies mutant for both mus309 and Polα is interesting, in 
that it is a similar shape as the distribution detected with wild type Polα.  The regions from net-dp 
and b-pr appear to be fragile in both of these genetic backgrounds.  The similarity of these 
distributions is consistent with the notion that regions affected by endogenous lesions – that is to 
say, the natural CFSs – are the same as those damaged while under replicative stress, the induced 
CFSs.  This supports the hypothesis that DNA sequence plays a substantial role in CFS fragility.  
While the timing of replication, for example, is likely to be different in flies with reduced levels 
of Polα, the sequence of the chromosomes remained constant between the two backgrounds. 
The implication that natural and induced CFSs may be the same is important, as it would 
indicate that CFSs are more than aphidicolin-sensitive regions.  It may be, for example, that CFSs 
are not simply sensitive to the polymerase-slowing effects of aphidicolin alone; rather, it appears 
to be the combination of aphidicolin and a natural tendency for replication forks to stall in that 
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region that leads to chromosome breaks.  In this scenario, the aphidicolin serves to push the 
regions that are already sensitive to endogenous fork stalling above the threshold of detection.  
This is consistent with a study that found CFSs in human cells lacking ATR exhibited instability 
even in the absence of aphidicolin (CASPER et al. 2002). 
This connects to previous work from our lab, in which the reduction of the levels of Polα 
was studied (LAROCQUE et al. 2007a).  Mutation of Polα alone did not produce any detectable 
genome instability phenotypes.  However, when Polα was mutant in a background mutant for 
mei-41, which encodes the D. melanogaster ortholog of ATR, increases in apoptosis, loss of 
heterozygosity, and male germline mitotic crossovers were detected.  Mutation of mei-41 by itself 
was also found to have a significantly higher rate of genome instability relative to wild type.  This 
indicates another situation in which cells are prone to endogenous damage, and where this effect 
can be exacerbated by the replicative stress of Polα reduction. 
Interestingly, in that same study, mutation of one of the mitotic cyclins, cyclin A (CycA), 
was found to rescue the apoptosis phenotype of mei-41; Polα/+ back to the levels observed in 
mei-41 mutants.  One interpretation of this result is that mutation of cyclin A slows the cell cycle, 
giving the cell more time to deal with the damage and stalled forks incurred from the reduction of 
Polα and lack of mei-41.   CycA mutation could not, however, reduce the levels of apoptosis 
observed in mei-41 mutants.  This suggests that Polα and mei-41, both of which have been shown 
to induce fragile regions in other organisms even without aphidicolin treatment, may affect 
genome stability in different ways.  Polα reduction appears to result in a deleterious effect that 
can be ameliorated with enough time; perhaps it causes replication forks to slow or stop in a 
manner that doesn’t require MEI-41 to fix.  On the other hand, flies mutant for mei-41 do not 
appear to receive any benefit from a slower cell cycle.  This effect of the mei-41 mutation may be 
due to a possible DNA repair function that has been proposed for mei-41, beyond its role as a cell 
cycle regulator (LAROCQUE et al. 2007a; LAROCQUE et al. 2007b). 
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Connections between DmBLM & CFSs 
The DmBLM mutation may have had additional effects beyond simply allowing us to 
visualize DSB repair events as mitotic crossovers.  Human BLM has been shown to be associated 
with ultra-fine DNA bridges in normal cells (CHAN et al. 2007).  The presence of these bridges is 
elevated in cells that lack BLM; it has been inferred that the bridges represent catenated, 
intertwined DNA between sister chromatids, and that BLM is involved in promoting the 
necessary decatenation.  Strikingly, it was later shown that these ultra-fine bridges are associated 
with many CFSs after treatment with aphidicolin (CHAN et al. 2009).  This supports a model in 
which CFSs are among the last portions of the genome to be replicated, and require BLM to 
disentangle from the sister chromatid.  If replication is slowed by an exogenous agent, CFSs are 
left either entangled or unreplicated – consistent with work showing that BS cells have slow 
replication (RASSOOL et al. 2003).  Either way, this could easily lead to DNA breaks.  Indeed, 
spontaneous chromosome breaks in BS patients have been found to be significantly associated 
with CFSs (FUNDIA et al. 1995).  In my assay, regions exceptionally prone to breaks in mus309 
Polα mutants are the same as those prone to breaks in flies mutant for mus309 alone.  Due to the 
association of BLM with CFSs detected in human cells, the similarity between the distribution of 
induced and natural CFSs presented here suggests that this relationship is present in Drosophila, 
as well.  As BLM has been proposed to prevent the collapse of stalled replication forks, this 
relationship provides further evidence that fork stalling occurs at CFSs even in the absence of 
replication inhibition. 
It is interesting to note that the distribution of mitotic crossovers I detected is very 
different from the distribution of meiotic crossovers (e.g. MCVEY et al. 2007).  For example, 
based on the meiotic crossover rate, the region distal to the centromere, net-dppd-ho, would be 
expected to have a very low rate; the region between P-b would be expected to have a high rate.  I 
observed the opposite effect (Figs 2.2 and 2.5).  This suggests that the relative elevation of 
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mitotic crossovers in fragile regions is truly due to the repair of DSBs, and not due to any 
inherent propensity for forming crossovers. 
Having determined the location of CFSs due to replication-associated damage, I aim to 
resolve these mitotic crossovers at a higher resolution.  Examining the sites at a high resolution 
will allow me to determine if the sites I detected display clustering beyond what I was able to 
detect with my megabase-resolution phenotypic markers.  Detection of such clustering would 
allow one to not only identify the boundaries of the fragile regions, but also to focus on the most 
fragile portion of the region in subsequent analyses of the causes of fragility.  To facilitate such 
future studies, I have prepared crossovers for SNP mapping via high-throughput sequencing.  
This has entailed additional crosses of crossover flies, the creation of stocks containing balanced 
crossovers, and the freezing of flies in which I’ve recapitulated the genotype of the original 
crossover male (e.g., al dp b pr cn/CO) (Fig 2.4).  I have commenced sequencing of reciprocal 
crossover products; as it is often difficult to recover both halves of a mitotic crossover in 
metazoans, this will give us a unique opportunity to study DNA repair in a mus309 mutant 
background.  
In summary, I have demonstrated that CFSs are present in D. melanogaster.  Two fragile 
regions appear to be present on 2L, based on natural and induced replication difficulties.  
Comparison of the results obtained with normal and reduced levels of Polα suggest that inhibition 
of replication pushes natural CFSs above the threshold of detection in tranditional CFS assays.  
Future studies will use higher resolution approaches to ascertain the distribution of endogenous 
DSBs within the 2L fragile regions.  I have laid the foundation for such studies by freezing CO 
flies in anticipation of SNP mapping of the COs via high-throughput sequencing.  Such analyses 
will aid in determining the causes of fragility. 
 
Materials and Methods 
Drosophila stocks and genetics 
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Flies were reared on standard medium at 25 C, and virgined at 18 C overnight.  The 
marker chromosome stock used for initial crossover experiments was net dppd-ho dp b pr cn; 
mus309N1/TM6B.  Males of this stock were crossed to females of genotype P{SUPor-P}GlcAT-
SKG01446; mus309N1/TM6B.  Male progeny that were homozygous for mus309N1 and heterozygous 
for the 2nd chromosome were crossed to net dppd-ho dp b pr cn females; the progeny of that cross 
were scored for mitotic crossovers between the phenotypic makers.  Crossovers that occurred 
between dp and b were further characterized via PCR to determine if they occurred proximal or 
distal to the P element.  For crosses in which one copy of Polα was removed, the marker 
chromosome stock was changed to net dppd-ho dp b pr cn; ru mus309N1 DNApol-α180 ca/TM6B.  I 
used the DEVIAT program developed by Mohamed Noor to perform bootstrapping to test if CO 
distributions were significantly non-uniform (CIRULLI et al. 2007). 
Crossover flies designed to be used for SNP mapping were obtained in a similar fashion, 
with the following differences.  Parental males were al dp b pr cn/SM6a; mus309D2/TM6B, and 
parental females were w; cn bw sp; mus309N1/TM6B.  The second chromosome of the females 
was derived from the reference sequence stock, available from the Bloomington stock center.  
Male progeny that were heteroallelic for mus309 and heterozygous for the 2nd chromosome were 
crossed to al dp b pr cn females; progeny of that cross were scored for mitotic crossovers.   
If at least one crossover fly of that cross was a male, an attempt was made to make a 
balanced stock of the crossover chromosome.  The crossover-bearing male was crossed to y; 
Pin/SM6a, al dp sp; the al, dp, and sp on SM6a were used in the following generation to 
distinguish the crossover chromosome from the marker chromosome.  Siblings that carried both 
the crossover chromosome and SM6a were crossed to each other to make a stock. 
If al and dp were both present on the initial crossover chromosome, there was a 
possibility that sp had been crossed off in an unrelated mitotic crossover.  To avoid this situation, 
which would make it difficult to distinguish between the marker and crossover chromosomes, the 
male was first crossed to net dppd-ho dp wgSp-1 b pr cn/SM6a.  Male progeny of this cross that were 
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not balanced on the 2nd chromosome were crossed to y/y+Y; Pin/SM6a, al dp sp females, and the 
appropriate progeny were crossed to make a stock, as above. 
Males that were to be used for SNP mapping via high-throughput sequencing were 
crossed to al dp b pr cn.  Typically, this was done from a balanced crossover stock, but it could 
also be performed directly from the initial male that manifested the crossover.  All progeny of the 
genotype al dp b pr cn/CO were collected and frozen at -80 C to await library preparation.  The 
purpose of this approach was to generate multiple flies that had identical 2nd chromosome content, 
thus providing additional DNA for sequencing library preparation. 
 
PCR analysis 
The first crossover detection scheme used PCR to determine if crossovers between dp 
and b occurred proximal or distal to the P element.  DNA was obtained via single-fly squishes 
(GLOOR et al. 1993). The primers were GTCTAGTGCCAGGCTACTCG and 
GCGGACCACCTTATGTTATTTC; the annealing step was 65 C, the extension step was 30 
seconds, and 35 cycles were run.  
 
 
 
 
 
Chapter III 
Common Fragile Sites and Exogenous DNA Insertions 
 
Introduction 
I showed in Chapter II that D. melanogaster has common fragile sites (CFSs) on the left 
arm of chromosome 2.  This encouraged me to look for CFSs across the genome as a whole.  I 
approached this study aiming to design a CFS detection assay that was both high-resolution and 
genome-wide.  To accomplish this, I took advantage of a property that CFSs have in addition to – 
and likely because of – their propensity to incur DNA breaks. 
It has been demonstrated that CFSs have a tendency to take up DNA from exogenous 
sources.  This has been shown to be the case with aphidicolin-treated human/hamster hybrid cells, 
in which a selectable DNA cassette was found to preferentially integrate in FRA3B, a known 
human CFS (RASSOOL et al. 1991).  In this study, the authors used fluorescence in situ 
hybridization to identify the chromosome band in which the integration took place.  They found a 
significant hybridization in FRA3B in aphidicolin-treated cells; cells that had not been treated 
with aphidicolin had a more diffuse integration pattern, but did contain a site of non-random 
integration in the hamster portion of the DNA.  It is unclear if the non-random integration in cells 
without aphidicolin was due to sequence characteristics of the construct, or if the integration site 
constitutes a natural CFS.  Either way, the work represents the first experimental investigation of 
DNA integration at CFSs. 
Similar tendencies to take up exogenous DNA, can be found in viral integrations 
(POPESCU et al. 1990).  In this study, the authors reviewed the literature on integration sites of 
DNA-containing viruses, and found that the majority integrated in chromosome bands containing 
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a CFS.  Additional studies have found integrations of HPV16 within numerous CFSs (THORLAND 
et al. 2000; WILKE et al. 1996). 
Non-random integrations at CFSs have also been detected in breast cancer cell culture 
(MATZNER et al. 2003).  The MDA-MB-436 cell line was known to spontaneously express CFSs; 
the authors used fluorescent in situ hybridization to tag integrations of a selectable construct at 
these sites.  Many of the integrations were found to co-localize to canonical CFSs, while the 
others integrated at other spots of known spontaneous breakage in the unstable cell line. 
This propensity to take up exogenous DNA is likely due to the instability of CFSs, 
especially when under conditions that put the genome under stress; DSBs have been shown to 
take up ectopic DNA in S. cerevisiae (HAVIV-CHESNER et al. 2007; MOORE and HABER 1996).  
Several human CFSs were first able to have their sequence analyzed due to an approach based on 
the cloning of inserted DNA (MISHMAR et al. 1998; RASSOOL et al. 1996). 
I designed an assay to take advantage of the integration-prone characteristic of fragility.  
My goal was to identify putative fragile regions, rather than to characterize known CFSs.  I 
incorporated the idea of introducing a selectable construct to cells, but also included high-
throughput sequencing (HTS) to efficiently identify integration sites at a high resolution.  The 
assay can be used with or without aphidicolin, and may thus be used to gauge the effect of 
replicative stress on DNA integration.   
My assay has been successfully used to identify multiple DNA integration sites, thus 
providing evidence for the possible location of CFSs.  Analysis of these sites has provided 
information about the type of DNA repair used to integrate the foreign DNA, as well as 
information about the factors that contribute to fragility. 
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Results 
The integration assay identifies putative fragile regions 
I designed a novel assay to locate integration sites of a linear, selectable DNA construct 
into the genome of D. melanogaster S2 cells (Fig 3.1).  Briefly, the construct was transfected into 
cells in the presence of aphidicolin, and the construct was selected for; the insert-containing 
genomic DNA was then harvested and used for either HTS or TOPO cloning; either method 
could be used to identify the location of multiple insertions with a very high resolution.  The HTS 
method relies on paired-end sequencing to identify fragments that contain both insert and 
genomic DNA, while TOPO cloning simply sequences across the junction. 
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When cells transfected with 500 ng of construct were analyzed via HTS, I was able to 
detect 23 unique, unambiguous integrations of the construct with an initial resolution of less than 
400 bp (Fig 3.2 A, Table 3.1).  The high resolution is due to the size to which DNA fragments are 
sheared during HTS library prep.  Five additional insertion events from this initial pool were 
identified, but due to their integration into natural transposable elements, their exact location 
Figure 3.1. Cell-based DNA integration detection scheme. I have designed an assay that 
will allow one to map DNA integration sites across the entire genome, indicating putative 
fragile regions.  A modified, linear version of the pCoHygro vector was used.  It contains a 
gene conferring hygromycin resistance (light blue box), flanked by Drosophila gypsy 
insulators (pink boxes).  The construct is transfected into S2 cells, with or without aphidicolin 
treatment (1).  Stable integrations (2) can be selected by treating cells with hygromycin, or 
cells can be harvested as soon as they regain confluence.  Genomic DNA is depicted here as 
orange lines.  The DNA is extracted from the cells and sheared to ~400 bp fragments via 
sonication (3). Sequencing adapters are added to the ends of the fragments, allowing them to 
be sequenced on the Genome Analyzer IIx (Illumina; 4).  The resulting 36 bp paired-end 
reads allow one to pinpoint the integration site of multiple insertions, indicating potential 
CFSs on a genome-wide scale (5).  
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could not be ascertained from HTS alone.  The possible sites of their integration are presented, 
relative to the D. melanogaster reference sequence (Fig 3.2 B).   
 
Figure 3.2. Integration of aphidicolin-induced DNA inserts.  Integration events of 
pCoHygro into S2 cell DNA in the presence of aphidicolin were mapped with a variety of 
techniques.  Those that could be unambiguously mapped to a single location are presented 
here relative to the D. melanogaster reference sequence assembly (A).  Depicted are 
insertions detected in cells transfected with 500 ng of linear pCoHygro and selected with 
hygromycin for 19 days, detected with GA IIx sequencing (23 inserts, blue diamonds) or 
splinkerette PCR and TOPO-TA cloning (2 inserts, green), and cells transfected with 5 ng of 
linear pCoHygro and grown for 7 days without selection, detected with GA IIx sequencing of 
splinkerette PCR products (27 inserts, red), or TOPO-TA cloning (2 inserts, orange).  The 
possible integration shites of the five ambiguous integrations from the 500 ng GA IIx sample 
are presented in (B).  Every possible integration site of those five inserts are depicted as light 
blue diamonds; unambiguous inserts from this pool are blue diamonds, as in (A).  Stacked 
diamonds are inserts within 20-155 kb of each other.  Light blue blocks, euchromatin; dark 
blue blocks, heterochromatin; circles, centromeres. 
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I found that, even when transfecting 100-fold less DNA, I was able to detect 
unambiguous integrations.  In this iteration of the experiment, splinkerette PCR was used to 
enrich for insert-containing sequences after the extracted DNA had been sheared (Fig 3.3).  
Splinkertte PCR involves the annealing of a “splink” adapter to both ends of each sheared 
fragment (DEVON et al. 1995; UREN et al. 2009).  The hairpin structure on the adapter is designed 
Table 3.1. Location of unambiguous integrations in aphidicolin-treated cells selected 
with hygromycin.  These integrations came from the first electroporation of S2 cells with 
500 ng of the construct.  Displayed are the possible ranges that contain the insert-genome 
junction for a given integration.  In instances in which the precise location was determined, 
only one number is given.  An asterisk indicates that a precise junction of the insert and 
genome was determined, but that there was microhomology.  The colors correspond to those 
used in Fig. 3.2: blue inserts were detected via HTS, and the green inserts were detected via 
TOPO cloning of splinkerette PCR products.  The green insert on 2L landed in the histone 
locus, but could not be placed to an unambiguous location.  All locations refer to release 5 of 
the D. melanogaster genome.   
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to prevent “end-repair” priming during PCR, in which unligated DNA anneal and amplify 
fragments that do not contain the insert.  In the first round of PCR, one of the two primers used 
matches the sequence in the single-stranded region of the splink; that is, it has no complementary 
sequence, and can therefore not initiate DNA synthesis.  The other primer used is an insert-
specific primer, which accomplishes first-strand synthesis only in fragments that contain the 
corresponding portion of the insert.  Synthesis from the insert-specific primer produces the 
complementary sequence that the splink primer needs to continue the PCR.  Therefore, even 
though the majority of the DNA fragments are nothing but genomic DNA, splinkerette PCR can 
enrich for DNA fragments that contained insert DNA.  In this manner, I detected an additional 27 
unambiguous integrations in cells transfected with 5 ng of construct (Fig 3.2 A, Table 3.2). 
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Figure 3.3. Splinkerette PCR enriches for insert-containing fragments. Following 
sonication of the DNA, blunt splinkerette adapters (red) are ligated to the ends of the sheared 
fragments.  An insert-specific PCR primer is employed to enrich for insert-containing 
fragments, while the hairpin on the splinkerette adapters prevent end-repair priming (1).  A 
second round of PCR further amplifies sequences of interest, while shortening the terminal 
non-genomic DNA (2).  Sequencing adapters are added to the ends of the PCR products, 
allowing them to be sequenced on the GA IIx (3,4).  The resulting 76 bp paired-end reads 
allow us to pinpoint the integration site of multiple insertions (5).  Alternatively, the product 
of the nested PCR from (2) can be cloned into a TOPO-TA vector and transformed into E. 
coli (6).  Colony PCR is used to detect successful cloning, and sequencing of the PCR 
products facilitates detection of the insert-genome junction (7). 
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The products of splinkerette PCR were also used for TOPO cloning, a system that allows 
direct cloning of PCR products.  By doing so, I was able to maximize the resolution of the insert-
genome junction, at the cost of some of the throughput.  TOPO cloning of the 500 ng transfection 
revealed two additional inserts: an unambiguous integration on 3R, and an insertion in the 
Table 3.2. Location of unambiguous integrations in aphidicolin-treated cells enriched 
via splinkerette PCR.  These integrations came from the second electroporation of S2 cells, 
which used 5 ng of the construct.  Displayed are the possible ranges that contain the insert-
genome junction for a given integration.  In instances in which the precise location was 
determined, only one number is given.  The colors correspond to those used in Fig. 3.2: red 
inserts were detected via HTS of splinkerette PCR products, and the orange inserts were 
detected via TOPO cloning of splinkerette PCR products. All locations refer to release 5 of 
the D. melanogaster genome.  
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repetitive DNA of the histone locus on 2L (Fig 3.2 A, Table 3.1).  The 5 ng transfection sample 
was found to contain two additional unambiguous integrations (Fig. 3.2 A, Table 3.2).   
The assay was also used to detect integrations in the absence of aphidicolin.  The 
procedure was similar to that described above, with three exceptions.  First, the inserted construct 
was slightly different: I used a version that did not contain the gypsy insulators.  As these regions 
are D. melanogaster sequences, I removed them to eliminate potential integration bias, and to 
simplify insertion mapping.  Second, the S2 cells were not exposed to aphidicolin.  Third, in order 
to maximize the heterogeneity of the final pool of inserts, electroporated cells were split into 
twelve wells of 24-well plates immediately after transfection.  By performing hygromycin 
selection in twelve wells instead of one, the total cell population could not become completely 
homogenous due to selective growth.  Therefore, the diversity of inserts at the end of the selection 
process was anticipated to be greater.  The high-throughput sequencing analysis of inserts 
generated in such a manner allowed me to detect seven integrations that took place without the 
presence of aphidicolin (Fig. 3.4, Table 3.3). 
 
Figure 3.4. Integration of DNA inserts without aphidicolin.  Integration events of 
pCoHygro into S2 cell DNA were mapped with HTS; those that could be unambiguously 
mapped to a single location are presented.  Depicted are insertions detected in cells 
transfected with 500 ng of linear pCoHygro and selected with hygromycin for 15 days, 
detected with GA IIx sequencing.  Light blue blocks, euchromatin; dark blue blocks, 
heterochromatin; circles, centromeres.  
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Integration analysis: insert-genome junctions 
In analyzing the integrations, I first focused on the sequence of insert-genome 
boundaries.  The uptake of exogenous DNA requires some means of DNA repair, and the 
sequence of the junctions provides a “signature” to suggest what type of repair was used.  I took 
two approaches to analyzing the junctions.  The first was to use sequence data obtained from 
high-throughput sequencing to design primers to amplify insertion junctions that were known at 
the 400 bp resolution.  The PCR products were then sequenced; two integrations were analyzed in 
this way (Table 3.4).  The second approach was to examine the initial sequencing data to see if 
one of the sequencing reads spanned the junction.  The four integrations that had been detected by 
TOPO cloning necessarily had one junction that was known to single-bp resolution, and five of 
the seven non-aphidicolin inserts had at least one read that spanned the junction (Table 3.4). 
Table 3.3. Location of unambiguous integrations in cells selected with hygromycin.  
These integrations came from the third electroporation of S2 cells, which used 500 ng of the 
construct but no aphidicolin.  Displayed are the possible ranges that contain the insert-genome 
junction for a given integration.  In instances in which the precise location was determined, 
only one number is given.  An asterisk indicates that a precise junction of the insert and 
genome was determined, but that there was microhomology.  The color corresponds to that 
used in Fig. 3.5: all inserts were detected via HTS.  All locations refer to release 5 of the D. 
melanogaster genome.  
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Analysis of the junctions revealed differences between aphidicolin and non-aphidicolin 
integrations.  Non-aphidicolin inserts had a more frequent use of microhomology, in which the 
junction contains a short (1-10 bp) stretch of nucleotides that match both the insert and the 
genomic sequence (Fig 3.5, Table 3.4)(MCVEY and LEE 2008).  It is unclear if the single instance 
of imperfect microhomology is due to a mismatch or a SNP in the S2 DNA relative to the 
reference sequence.  Aphidicolin integrations had a higher rate of small (1-10 bp) insertions 
between the construct and genomic DNA, the source of which is unclear.  These data are 
consistent with an interpretation in which, in the absence of aphidicolin, microhomologies play a 
substantial role in determining the precise location of integration; when aphidicolin is present, the 
criteria are not as strict. 
Table 3.4. Sizes of insertions and microhomology at integration-genome junctions.  All 
11 junctions analyzed are listed.  The size of these events is given in base pairs. The color 
corresponds to those used in Figs. 3.2 and 3.5; colored integrations came from cells treated 
with aphidicolin, and black integrations came from cells that were not.  The “8/9” indicates 
imperfect microhomology, in which only 8 of 9 possible bases between the construct and the 
reference genome matched.   
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In situations where I did not determine the exact junction, I used the size of the HTS 
library band, adapter length, and read length to determine the minimal range that could contain 
the junction.  For example, the band size of the 500 ng aphidicolin-treated library was about 500 
bp, the read length was 36 bp from either end, and both sides of each fragment had 33 bp worth of 
Illumina adapter attached.  The amount of unknown DNA in the 500 bp span was therefore: 
500-(2*36)-(2*33) = 362 bp 
For a conservative estimate, I rounded the possible junction range up to 375 bp (Table 3.1).  
Using similar calculations, I determined the range of the 5 ng sample to be 250 bp (Table 3.2).  In 
the two cases in which the junctions of the 500 ng non-aphidicolin sample were not already 
known, the possible range was 200 bp (Table 3.3). 
Figure 3.5. Microhomology at insert-genome junctions.  The sequence of the insert-
genome junctions that were detected to have microhomology is presented above.  Only 
070110ins_5 had imperfect microhomology, represented by the T that corresponds to the 
insert, but not the reference genome.  Insert DNA is represented in blue, genomic DNA in 
orange, and microhomology in green.  
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In at least two of the three transfections presented here, the position of the insert end of 
the paired-end reads indicates that the integration did not involve the entire plasmid (Fig 3.6).  
The inserts recovered from the splinkerette-enriched sample, shown in red, are likely from intact 
constructs – the reads could all theoretically fit the end of the construct within the space of the 
400 bp fragment used for sequencing (Fig. 3.6 B).  The other two samples, however, have 
construct reads that are kilobases away from either end of the construct, indicating that only part 
of the construct was integrated at that site (Fig 3.6 A, C).  This could be indicative of 
fragmentation or degradation of the construct prior to integration, or the use of homologous 
recombination to take up only part of the linear construct.   
 
 
Figure 3.6. Position of insert reads suggest fragmented integrations.  The position and 
orientation of the unambiguous sequencing reads are depicted.  Blue arrows are reads from 
the 500 ng sample + aphidicolin (A).  Red arrows are the reads from the 5 ng sample + 
aphidicolin, enriched with splinkerette PCR.  The PCR selects for the terminal 139 bases, 
depicted here (B).  Black arrows represent reads from the 500 ng sample that was not treated 
with aphidicolin.  This version of the construct did not contain the gypsy adapters; hence, it is 
shorter. 
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Integration analysis: local genomic environment 
As noted above, the location of integration events is expected to correlate with D. 
melanogaster CFSs.  Therefore, the most interesting regions from this experiment, with regard to 
CFSs, are those in which multiple insertion events cluster.  However, every integration site is 
informative in the sense that there was something about that region that was amenable to taking 
up exogenous DNA.  I analyzed these sites to determine what features gave the sites this fragile 
characteristic.  I aimed to take advantage of my high-resolution, high-coverage approach to CFS 
characterization by analyzing the local genomic environment of the integration sites.   This was 
accomplished largely by using data from the modENCODE project and leveraging the Galaxy 
bioinformatics framework (BLANKENBERG et al. 2010; CELNIKER et al. 2009; EATON et al. 2011; 
GOECKS et al. 2010).   
The inserts were recovered at a relatively high rate per experiment, with 53 inserts 
coming from only two transfections involving aphidicolin, and an additional seven insertions 
from a transfection without aphidicolin.  However, because we have little a priori indication of 
where D. melanogaster CFSs might be located, analysis of what makes these regions fragile 
would benefit from additional integration events.  Future iterations of the integration assay will 
no doubt assist in this aim.  Still, integration in the presence of aphidicolin does constitute 
evidence of chromosome fragility.  With that in mind, I analyzed my integrations in terms of 
genomic factors that have been proposed to contribute to fragility.  This was typically done by 
comparing the characteristics of my two integration sets – those treated with and without 
aphidicolin – to corresponding datasets of identically-sized intervals placed at locations 
determined by a random number generator.  The random regions were designed to take the copy 
number variation of S2 cells into account (ZHANG et al. 2010). 
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Table 3.5. Local genomic environment of aphidicolin-induced inserts.  All values were 
determined using tracks from the modENCODE genome browser.  Timing is the timing of 
replication from the S2 replication timing track.  Values are the log2 ratio of early to late 
replicating sequences at the probe nearest the insertion window; positive values indicate early 
replication.  Distance is the distance, in base pairs, to the nearest origin of replication, 
determined from the S2 dOrc2 track.  A 0 indicates that the window overlapped an origin.  
Density is the number of origins within 100 kb of either side of the insertion window, again 
determined by S2 dOrc2 signals.  %GC is the GC content of the insertion window, calculated 
using the EMBOSS geecee tool in Galaxy.  
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Sequence composition:  In humans, CFSs tend to be AT-rich, although no specific motifs 
have been found to be associated with fragility (LUKUSA and FRYNS 2008).  The 100 bp flanking 
regions surrounding my inserts tended to consist mostly of AT content.  The means of the 
insertion windows were significantly different than the means of the random sites for aphidicolin-
treated cells, but not for non-aphidicolin cells (aphidicolin-treated: P = 0.0145; non-aphidicolin: 
P = 0.3060, Mann-Whitney U test).  On average, the aphidicolin-treated cells had a higher GC 
content than the random regions (45% vs. 42%). 
 
Replication timing: CFSs in other models tend to be late-replicating, and may be origin-
poor.  It has been reasoned that these regions are fragile because they are unable to replicate their 
DNA by the end of S phase, especially in the presence of replication-inhibiting aphidicolin.   
Taken as a whole, I found considerable variability in the timing of replication of my 
integration sites (Tables 3.5, 3.6).  The mean replication timing did not appear to differ from that 
of the random regions (aphidicolin-treated: P = 0.0623; non-aphidicolin: P = 0.4924, t-test).  I 
Table 3.6. Local genomic environment of inserts incurred without aphidicolin. All values 
were determined using tracks from the modENCODE genome browser.  Timing is the timing 
of replication from the S2 replication timing track.  Values are the log2 ratio of early to late 
replicating sequences at the probe nearest the insertion window; positive values indicate early 
replication.  Distance is the distance, in base pairs, to the nearest origin of replication, 
determined from the S2 dOrc2 track.  A 0 indicates that the window overlapped an origin.  
Density is the number of origins within 100 kb of either side of the insertion window, again 
determined by S2 dOrc2 signals.  %GC is the GC content of the insertion window, calculated 
using the EMBOSS geecee tool in Galaxy.  
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also calculated the distance to the nearest origin of replication, which I identified based on the 
peak calls of the S2_dOrc2 subtrack of the modENCODE ChIP-Seq dORC2 track.  This track 
was generated by immunoprecipitation of the origin recognition complex subunit 2, which binds 
to origins of replication.  This distance varied substantially between different inserts, from those 
that overlapped an origin to those that were almost 150 kb away.  Those that were furthest away 
from origins did not necessarily have the latest replication, however, speaking to the complexity 
of the replication protocol of the cell (Tables 3.5, 3.6).  The mean distance of the insertion 
windows was not significantly different from that of the random regions (aphidicolin-treated: P = 
0.1665; non-aphidicolin: P = 0.3176, Mann-Whitney U test).   
The local density of origins of replication was also considered.  I counted the number of 
origins, represented by dOrc2 peaks, that were within 100 kb of either side of the initial search 
window.  I did not detect any significant difference between means of the aphidicolin-treated and 
random samples (aphidicolin-treated: P = 0.4126; non-aphidicolin: P = 0.9491, t-test).   
 
Discussion 
I have used a high-resolution, genome-wide DNA integration assay in D. melanogaster 
cells to identify regions exceptionally prone to taking up exogenous DNA, a characteristic of 
CFSs.  In doing so, I detected evidence that suggests S2 cells may use different repair 
mechanisms to integrate exogenous DNA, depending on whether or not they are under replicative 
stress.  My analysis of integration sites suggests that the causes of fragility are likely due to a 
combination of factors, as no single factor I investigated was sufficient to explain the fragility of 
the insertion sites. 
 
Aneuploidy in S2 cells  
S2 cells have a stable genotype, but are aneuploid for at least 43 Mb of the genome and 
contain many rearrangements (ZHANG et al. 2010).  Because of this, there is not a sequence 
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assembly for S2 cells.  This makes analyzing the relative location of inserts difficult – that is, 
unknown rearrangements prevent me from being able to determine the extent of clustering.  
However, this has little effect on the validity of individual inserts, due to the high resolution to 
which the sites have been mapped.  That is, the features near each integration can be reliably 
determined, but the distance between integration events cannot.   
A similar issue affects the pool of ambiguous inserts, all of which occurred in natural 
transposable elements (Fig. 3.2 B).  The location of transposable elements in S2 cells may differ 
from those of the reference sequence, so the potential insertion sites depicted in Figure 3.2 may 
not be accurate.  What Figure 3.2 B serves to illustrate, however, is that the nature of transposable 
elements means that the five ambiguous inserts have numerous possible integration sites. 
 
Replication inhibition may influence DNA repair 
The insert-genome junctions analyzed here suggest that replicative stress affects the 
relative usage of microhomologies in the integration of exogenous DNA.  Integrations in cells 
that had been treated with aphidicolin appeared to use microhomology less frequently than cells 
not treated with aphidicolin.  In the absence of aphidicolin, exogenous DNA may be easiest to 
integrate in genomic regions with similar sequence.  By adding aphidicolin, there may be a 
relaxing of the requirement for similar sequence, and/or an increase in the number of potential 
integration sites.  This may occur because of additional replicative stress introduced by 
aphidicolin, in which the inhibition of replicative polymerases leads to chromosomal gaps and 
breaks that could take up exogenous DNA during repair.  The results here suggest that this is an 
issue worthy of additional study.  Future experiments will examine additional insert-genome 
junctions, including those that exist on the side of the integration not detected by HTS.   
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Integration data suggests fragmentation of the construct 
The location of sequencing reads within the construct suggests that many integration 
events did not involve the entire construct (Fig. 3.6).  In cases in which the hygromycin resistance 
gene was not integrated, it is likely that another integration that did contain hygromycin 
resistance occurred in the same cell, allowing the cell to survive selection.  The integration of 
only part of the construct is consistent with fragmentation or partial degradation of the construct 
prior to integration, or the use of homologous repair to take up only part of the construct.  
Information from the insert junctions suggest that the samples treated with aphidicolin appear to 
have an infrequent use of microhomology at the insert-genome junction (Table 3.4). In this 
instance, fragmentation of the insert is a more plausible explanation than homologous repair.  For 
the black, non-aphidicolin sample, where microhomology is more prevalent, the distinction is not 
as clear.  However, as the sections of homology appear to be relatively small, repair involving 
fragmented DNA is likely a more plausible explanation than homologous repair. 
 
Interpretation of insert environment 
The possibility of multiple factors affecting integration underscores the complexity of 
chromosome fragility.  Instability at mammalian CFSs is likely due to a combination of several 
factors, and the results of my analysis of the S2 cell integration sites are consistent with a model 
in which Drosophila CFSs are just as complex.  From the analyses I have carried out so far, there 
does not seem to be a specific, single factor that these integration sites have in common, and 
which explains why they appear to be fragile.  It is interesting to note, however, that the insert 
regions of aphidicolin-treated cells have a significantly higher GC content than random regions of 
equal size (P = 0.0145).  The average GC content of said regions is 45%, consistent with the low 
GC content of human CFSs (SCHWARTZ et al. 2006).  Still, it is curious that the random regions 
had an even lower GC content of 42%.  Though the effect size appears to be small, the suggestion 
that GC content in putative CFSs is higher than expected by chance suggests that the contribution 
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of sequence to fragility need not be rooted in high AT content.  The small effect size further 
suggests that it is likely that the propensity for taking up exogenous DNA is due to a combination 
of factors. 
In addition, this study was able to uncover aphidicolin-sensitive sites that have many of 
the characteristics of human CFSs, such as high AT content and relatively late replication (Table 
3.5).  Integration sites such as 100109ins_28, 100109ins_22, and 032509ins_16, which have 
many of the proposed characteristics of fragility, will warrant close attention in the future. 
 
Factors affecting the insertion assay 
In developing the assay, I experimented with many of the methods involved to determine 
the optimum output.  Factors such as amount of input DNA, selection time, cell population 
heterogeneity, use of splinkerette PCR, and the insert detection scheme were all considered.  The 
amount of DNA used was a key factor; my initial concern was that the amount suggested by the 
Amaxa kit, 2 µg, might overwhelm the cell and lead to random integration, so I aimed to use as 
little of the linear insert as possible.  The first experiment went as low as 500 ng; in the second 
iteration of the experiment, I found I was able to identify insert-containing cells that had been 
exposed to as little as 5 ng of DNA.  Detection of the 5 ng sample did not involve selection with 
hygromycin, but was aided by splinkerette enrichment for insert-containing DNA fragments.  It 
may be that the assay can be implemented with even smaller quantities of DNA.  Investigations 
into the lower threshold of insertion-producing DNA should use some type of selection, such as 
hygromycin or splinkerette PCR. 
The amount of time between transfection and DNA harvest was important to consider, as 
well.  Selection was used to ensure the survival of insert-containing cells, but the longer cells 
were selected with hygromycin, the more homogenous the population would become.  To 
increase the heterogeneity of the population, I experimented with relatively short growth times of 
seven days, with no hygromycin treatment.  Although there was nothing to give insert-containing 
48 
cells a selective advantage during the week of growth, and the samples had been transfected with 
only 5 ng of DNA, I was able to use splinkerette PCR to detect about as many inserts as I had 
from cells transfected with 100 times as much DNA and selected with hygromycin.  The use of a 
selective agent, such as hygromycin, is therefore not critical to the success of the assay; however, 
some form of enrichment for insert-containing cells or sequences may be desirable.   
Timing, however, is not the only means of affecting insert heterogeneity in the cell 
population.  I experimented with physical separation of the cells to maximize the diversity of the 
insert pool.  If, after transfection, the cells were to be split into as many wells as possible, the 
overall pool of inserts would be able to avoid becoming completely homogenous, dominated by a 
few successful cells.  By growing cells in twelve small wells instead of one big well, one would 
expect to increase the number of inserts in the pool by about twelvefold.  To date, the only cells 
that were grown in this way that have been successfully sequenced were those grown in the 
absence of aphidicolin.  This library identified only seven unique inserts, but as the cell did not 
have aphidicolin to encourage genomic uptake of the construct, it is not surprising that these 
samples produced fewer inserts than those grown with aphidicolin.  Regardless, the reasoning 
behind the physical separation of cells to encourage heterogeneity is sound; this technique is 
likely to be useful in maximizing output of the assay. 
Splinkerette PCR was instrumental in detecting inserts in a pool that had been transfected 
with little DNA and not selected with hygromycin.  However, the efficiency of enrichment can 
likely be increased further.  The reasons for the initial difficulty of enrichment are not entirely 
clear, but likely arise from the fact that the insert-containing portion of the extracted S2 DNA is a 
very small fraction, and discrete banding patterns were not detected after the nested PCR.  The 
approach is effective, as inserts that underwent enrichment via splinkerette PCR were detected 
with both HTS and TOPO cloning.  Still, it is likely that this step could be made more efficient.  
The main suggested alteration is to use a DNA pool with as many inserts as possible, which can 
be encouraged by using 500 ng or more starting DNA, selecting with hygromycin, and physically 
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separating the cells.  Another way is to take advantage of the relatively high density of insert 
reads recovered in the splinkerette sample.  Despite having less than 3% of the length of the 
construct to work with, HTS of the splinkerette-enriched 5 ng sample detected more inserts than 
the 500 ng sample (Figs. 3.2 A & 3.6).  The fact that most integrations did not appear to involve 
an intact construct suggests that insert detection via splinkerette PCR could be enhanced by 
running multiple separate PCR reactions, each using an insert-specific primer situated in a 
different portion of the insert. 
The choice between the use of whole-genome HTS or TOPO cloning depends largely on 
the time and cost involved.  At current efficiencies, TOPO cloning is somewhat less expensive on 
a per-insert detected basis.  In addition, the longer reads available in the sequencing of colony 
PCR products of TOPO clones give a better chance to identify the location of the insert 
unambiguously, although the ambiguous integration detected at the histone locus demonstrates 
that this is not guaranteed.  Further, in TOPO cloning, detection of an insert necessarily implies 
detection of the insert-genome junction.  However, the throughput of TOPO clone-based 
detection is markedly slower, as most TOPO clones of splinkerette PCR products did not lead to 
insert detection.  In addition, while both the HTS and TOPO detection methods would benefit 
from improvements to integration enrichment via splinkerette PCR, HTS has the most to gain.  It 
is conceivable that such improvements could make HTS the more cost-efficient option in the long 
term. 
 
Materials and Methods  
Production of the Insertion Construct 
The inserted DNA construct was a modified, linearized version of the pCoHygro vector 
(Invitrogen, #K4120-01).  A QuikChange kit was used to introduce a silent mutation that 
removed a CviQI restriction site in the ampicillin resistance gene (Stratagene, #200515).  In the 
iterations of the experiment involving aphidicolin, gypsy element insulators were added flanking 
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the hygromycin resistance gene.  These insulators were extracted from the pP{RedH-Pelican} 
vector (GenBank accession #AY342347) by restriction digest and cloned into pCoHygro using 
the HindIII site at position 400, and the EcoICRI site at position 2287.  The construct was 
linearized by cutting with the restriction enzyme BspQI (NEB, #R0712S) for three hours, and gel 
purifying the product using Buffer QG (Qiagen, #19063) and a PureLink PCR purification kit 
(Invitrogen, #K3100-01).  The ends of the construct were made blunt by klenow (NEB, 
#M0210S). 
 
Integration of DNA 
pCoHygro was transfected into Drosophila S2 cells using the Amaxa Nucleofector and 
the Cell Line Nucleofector Kit V (Lonza, VCA-1003).  Cells were provided by members of the 
Rodgers laboratory.  Cells were maintained in Sf-900 II serum-free media (Invitrogen, 
#10902096) with 1x antibiotic-antimycotic (Invitrogen, #15240062), and kept in T25 and T75 
flasks (BD Falcon, #353014 and #353135, respectively).  Quantification of cells was done by 
counting 10 µl of a 1:10 dilution in a hemocytometer.   
4.5x106 S2 cells were used for each transfection.  Aphidicolin was dissolved in dimethyl 
sulfoxide (DMSO) to a 2 mg/ml concentration; a 40 µM working stock was made by diluting 1.35 
µl of the main stock in 200 µl of DMSO (Aphidicolin: Acros Organics, 1 mg, #611970010; 
DMSO, Sigma-Aldrich, 100 ml, #154938).  If aphidicolin was to be used in the treatment, it was 
added to the cells at a concentration of 0.4 µM, and allowed to sit for 30 minutes.  Cells were 
passaged to 1.5 µl tubes, and spun for 5 minutes at 2,000 rpm (381xG).  The media was removed, 
and each tube was resuspended in 90 µl Solution V from the Nucleofector kit.  About 10 µl of 
either 5 or 500 ng of pCoHygro DNA, depending on the experiment, was added to the cells.  
Cells were moved to a Nucleofector cuvette and electroporated using the S2 cells setting of the 
Amaxa machine.  Cells were then passaged to media in 6- or 24-well plates, depending on the 
experiment; if the sample had been treated with aphidicolin, this media also contained 0.4 µM 
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aphidicolin.  In some cases, a single cuvette worth of electroporated cells was split between 12 
wells of a 24-well plate. 
Transfected cells were grown until they had achieved greater than 75% confluence in the 
well; they were then passaged either to a T25 flask, or to another tissue culture plate.  Selection 
with hygormycin (Roche, #10-843-555-001) began when the cells again reached confluence, 
starting at 5 µl/ml and gradually increasing to 10 µl/ml.  Selection continued until cells reached 
>95% confluence in 10 µl/ml hygromycin; this took 15-19 days, depending on the experiment.  If 
cells were not treated with hygromycin, cells were grown for one week.  At the end of either time 
period, cells were harvested and their DNA extracted. 
 
Extraction of S2 cell DNA 
Cells were harvested by pipetting, and spun down in a 1.5 ml tube at for 5 minutes at 
500xG.  The supernatant was removed, the pellet resuspended in 1 ml ice-cold PBS, and the tube 
spun 5 minutes at 500xG.  After discarding the supernatant, cells were resuspended in 425 µl of 
digest buffer (100 mM NaCl; 10 mM Tris-HCl, pH 8.0; 25 mM EDTA, pH 8.0; 0.5% (w/v) SDS; 
0.1 mg/ml freshly-added proteinase K).  Samples were incubated at 50 C for 12-18 hours.  
Phenol/chloroform/isoamyl alcohol extraction was performed at least twice to purify the DNA. 
 
Insert detection by high-throughput sequencing 
Illumina library construction was performed using Illumina paired-end adapters (part 
#1001782) as described in the paired-end sample preparation guide (#1005063 Rev. D), with the 
following differences.  First, 5 µg DNA was fragmented via sonication using a Bioruptor 
(Diagenode, #UCD-200), and concentrated with the PureLink PCR purification kit (Invitrogen) 
prior to end repair.  End repair took place in a 50 ml reaction volume.  After the post-end repair 
column purification, size selection took place: the DNA was run on a 2% agarose gel for 60 
minutes, and DNA in the 350-400 bp range was extracted and purified.  During adapter ligation, 2 
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µl of adapter was used in a 30 µl reaction volume.  A second gel extraction on a 2% agarose gel 
was run as described in the original protocol.  The PCR to enrich adapter-modified DNA was 
carried out with 0.5 µl iProof high-fidelity polymerase (Bio-Rad, #172-5301), rather than Phusion 
polymerase.  The primers used were PAGE-purified oligos ordered from Integrated DNA 
Technologies, with the same sequence as those provided in the Illumina kit. 
In some cases, insert-containing DNA fragments were enriched via splinkerette PCR 
(UREN et al. 2009).  This was initiated by ligating blunt-end splinkerette adapters to the DNA 
fragments after the end-repair step.  A splinkerette primer 
(CGAAGAGTAACCGTTGCTAGGAGAGACC) and insert-specific primer 
(GGGGCGGAGCCTATGGAAAA) were used to amplify insert-containing fragments (35 cycles 
of PCR, 56 C annealing temperature, 1 minute extension); the products were further amplified 
by nested PCR (splinkerette: AGACTGGTGTCGACACTAGTGG; insert-specific: 
TTTGCTGGCCTTTTGCTC; 35 cycles of PCR, 58 C annealing temperature, 1 minute 
extension).  Primers were designed using Primer3 (ROZEN and SKALETSKY 2000).  At this point, 
the PCR product was either used to resume Illumina library prep by proceeding to the addition of 
Illumina PE adapters, or used for TOPO cloning. 
Libraries were sequenced on the Illumina Genome Analyzer IIx for 36-76 cycles.  Reads 
were mapped to the fly genome (release 5) and to the insert sequence using Bowtie (LANGMEAD 
et al. 2009); inserts were detected by filtering for clusters that had one sequencing read containing 
at least 30 nt of insert DNA, and a paired read with genomic DNA sequence.    
 
Insert detection by TOPO cloning 
Library preparation was begun as above, but after the addition of adenosine to the ends of 
each fragment, the DNA was subjected to cloning as per the TOPO TA cloning kit (Invitrogen, 
#K4500-01).  A 30 second heat shock was used to transform TOP10 E. coli cells, and colonies 
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were grown for ~16 hours on kanamycin-containing agarose plates.  Colonies were analyzed by 
using M13 primers for colony PCR (forward primer, GTAAAACGACGGCCAG; reverse primer, 
CAGGAAACAGCTATGAC); the PCR products were also sequenced using the M13 primers. 
 
Sequencing of insert-genome junctions 
When sequencing the junctions of inserts detected by HTS, I used the sequence 
information obtained from the GA IIx to design primers for PCR amplification.  Sequences were 
amplified for 35 cycles, with a 60.9 C annealing temperature and a 30 second extension, and 
sequenced via Sanger sequencing.   
 
Integration environment analysis 
The regions surrounding integration sites were analyzed with the Galaxy framework 
(BLANKENBERG et al. 2010; GOECKS et al. 2010).  Much of the analysis relied on data tracks 
from the modENCODE project (CELNIKER et al. 2009).  Insert intervals were compared to 
equally-sized intervals of random location; the random data was produced using the random 
number generator at random.org (HAAHR 1998).  Copy number variation was taken into account 
when generating random regions (ZHANG et al. 2010).  Statistical analyses were performed using 
the InStat software (GraphPad Software).  An unpaired t-test was used in cases in which the 
sample did not differ significantly from a normal distribution; the Mann-Whitney test was 
performed if this was not the case. 
 
 
 
 
 
 
 
Chapter IV 
General Discussion and Future Directions 
 
I have reported that CFSs are present in D. melanogaster, and have identified their 
location.  In doing so, I have explored the connection between induced and natural CFSs, and 
provided evidence of the connection between DmBLM and Drosophila CFSs.  My genome-wide 
assay has identified putative fragile regions at a high resolution.  In addition, I have produced two 
versatile assays that may be applied to future studies of CFSs, or to DNA breakage in general.  
Here, I provide further interpretation of the ramifications of my results, and propose future 
experiments to build on my findings. 
 
Evolutionary conservation 
The CFSs I have detected in D. melanogaster is in keeping with suggestions of 
evolutionary conservation implicated by studies that have detected fragile regions in budding 
yeast (ADMIRE et al. 2006; LEMOINE et al. 2005).  The reasons for the conservation of such a 
potentially deleterious genomic feature are unclear.  One possible explanation is that some useful 
genomic features may be necessarily fragile.  For example, many micro RNAs are located at 
human CFSs; the selective advantage provided by the micro RNAs may outweigh any detrimental 
effects of fragility (CALIN et al. 2004). 
Another possibility is that CFSs could be used for large-scale genomic rearrangements, 
such as translocations and inversions, and that a certain amount of these are necessary for the 
adaptability and survival of a species.  However, the mouse orthologs of specific human CFSs do 
not correlate with sites of evolutionary DNA rearrangements between the two species (HELMRICH 
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et al. 2006; HELMRICH et al. 2007).  Still, it may be that some CFSs involved in a large-scale 
rearrangement lose the characteristics that made them fragile, thus preventing one from finding an 
association between synteny breaks and CFSs.  To determine if this is the case, one would need to 
examine not only CFSs orthologous to known human CFSs, but also CFSs that do not necessarily 
have a human ortholog. 
If it turns out that CFSs are used for evolutionary large-scale rearrangements, this would 
suggest that either less derived organisms should have more CFSs than the more derived, or that 
new CFSs appear throughout evolution.  The fact that most of the CFSs detected have been 
described in humans could be seen as evidence for the second possibility, but it is important to 
keep in mind that human CFSs have received the most study.  If similar effort were put toward 
detecting and analyzing the CFSs of less derived organisms, such that we could be confident that 
we had a catalog of most or all CFSs in a given species, it would be easier to make an equivalent 
comparison.  The work presented here is a step in such a direction. 
A recent paper found that sites of recurrent evolutionary breaks, rather than functional 
constraints on chromosome breakage, are the most parsimonious explanation for the evolution of 
Drosophila chromosomes (VON GROTTHUSS et al. 2010).  The authors make reference to “fragile 
regions”, which they intend to refer to sites prone to breakpoint reuse in genome rearrangements 
on an evolutionary timescale, not the short-term fragility seen in RFSs and CFSs.  Still, as more is 
learned about Drosophila CFSs, it will be interesting to see if a meaningful relationship exists 
between CFSs and evolutionary breakpoints. 
 
Differences in the crossover and integration assays 
My crossover assay and my insertion assay provide different pictures of the fragility of 
2L.  For example, the crossover assay indicates the distal tip of 2L to be the most fragile part of 
the chromosome arm, but the insertion assay does not have any integrations in that region.  
However, this serves to underscore the relevant differences between the two experiments.  The 
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first is that tissue matters.  The crossover assay detects DSBs that takes place in the pre-meiotic 
male germline.  The insertion assay, on the other hand, uses S2 cells, which have the 
characteristics of macrophages (SCHNEIDER 1972).  Tissue-specificity of fragility has been 
reported in human cells, and has been suggested to be related to variations in replication timing 
profiles between cell types (LETESSIER et al. 2011).  Therefore, it may simply be that regions that 
are fragile in the male germline are not fragile in macrophages, and vice versa.  The aneuploidy 
of the S2 cells could also potentially affect these results (ZHANG et al. 2010). 
The second relevant difference between the assays is the status of DmBLM.  Mutations in 
mus309 were necessary in the crossover assay, as they drove the formation of the mitotic 
crossovers I mapped; there is no indication of mutated DmBLM in S2 cells.  Human BLM has 
been associated with CFSs, though, and DmBLM may play an active role in Drosophila CFS 
stability.  Human cells that lack BLM exhibit delayed replication, and BLM has been implicated 
in maintaining the integrity of stalled replication forks (DAVIES et al. 2007; RASSOOL et al. 
2003).  Furthermore, BLM associates with ultrafine anaphase bridges (CHAN et al. 2007), which 
may represent the entangled DNA of replicating chromosomes.  These bridges have been detected 
at CFSs (CHAN et al. 2009).  The overall implication is that BLM helps the cell recover from 
replication stress; in the absence of BLM, cells experience DNA breaks in the regions of 
chromosomes that are either unreplicated or contain DNA entangled with another chromosome.  
In short, BLM may be involved in preventing breaks at CFSs, so its absence could affect the 
distribution of CFSs observed. 
This issue lends itself well to future experiments.  Knockdown of genes in S2 cells via 
RNA interference is relatively straightforward (CLEMENS et al. 2000).  It should be possible, 
then, to knock down DmBLM in the cells while performing the integration assay.  If integrations 
on 2L in the absence of DmBLM matched the distribution produced by the crossover assay, it 
would suggest that DmBLM played a larger role than tissue specificity in influencing fragility.  If 
there were no change in the 2L integrations, it would suggest that tissue specificity played a larger 
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role; intermediate results would indicate a combination of the two factors as influencing fragility.  
This experiment could also be done with or without aphidicolin to investigate possible synergistic 
effects.   
Investigation of the physical location of DmBLM may serve as a useful future 
experiment, as well.  As noted above, the ultrafine bridges associated with human BLM are also 
associated with many CFSs (CHAN et al. 2007; CHAN et al. 2009).  Of importance is the fact that 
the bridges have been interpreted to be the entangled DNA of sister chromatids which require 
BLM to decatenate.  This interpretation, combined with the association with CFSs, means that the 
bridges may represent the regions of DNA that the cell has the greatest difficulty replicating.  
Precise localization of the bridges could thus be used to find the most fragile regions within a 
CFS.  A high-resolution way to examine such sites would be chromatin immunoprecipitation 
followed by HTS (ChIP-seq) (ROBERTSON et al. 2007).  One would crosslink proteins to DNA, 
shear the DNA, pull down DNA associated with DmBLM using an antibody, reverse the 
crosslinks, and use HTS to identify the sequences of the collected fragments.  These sequences 
would indicate where DmBLM had been bound at the time of the crosslinking, thus identifying 
the locations of the ultrafine bridges at a high resolution.  As such bridges have been detected in 
unperturbed human cells, the experiment could be done with or without treatment by agents like 
aphidicolin, providing another opportunity to examine the relationship between natural and 
induced CFSs.  Of course, such an experiment could also be carried out in human cell culture 
with an antibody for human BLM.  Versions of the experiment that pull down other proteins 
associated with the ultrafine bridges, such as FANCD2, are also possible (CHAN et al. 2009). 
 
Use of Eureqa for future studies 
The causes of fragility, and their relative contribution to the fragility of a given site, 
remain to be determined.  I believe a useful way to approach this is through application of the 
Eureqa software (SCHMIDT and LIPSON 2009).  This program was designed to identify 
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mathematical relationships between sets of data, and to do so in a way that non-trivial correlations 
are emphasized.  It does this by calculating equations that not only fit the data, but the partial 
derivatives of the equation also fit the derivatives of pairs of the data.  The software has been 
used to derive the calculations of natural laws; for example, data on the motion of a pendulum is 
sufficient for Eureqa to derive Force = mass * acceleration (SCHMIDT and LIPSON 2009).   
I propose to apply this technique to CFSs, to determine the relative contribution of 
various factors to making a region fragile.  One would have to determine a numerical way of 
representing fragility; initially, this would be easiest to accomplish with human data.  The 
fragility of specific CFSs relative to other CFSs is fairly well-established for the most fragile 
CFSs in humans (DENISON et al. 2003).  One could then provide Eureqa with the data on the 
fragility of various sites, along with factors such as replication timing and numerical 
representations of primary sequence characteristics, and anything else the user felt pertinent.  The 
utility of the equation produced by Eureqa would be to provide an estimate of the relative 
contribution of the different factors toward fragility.  In the pendulum example above, one can 
see that mass and acceleration contribute equally to determining the resulting force.  Such an 
approach should be able to guide future investigations into the nature of fragility, and provides a 
complementary approach to other multifactor analyses, such as multiple regression. 
 
Direct tests of fragility 
Future experiments should also directly test the characteristics implicated in fragility.  
Two good ways to do this would be to introduce fragility into a normally stable region, and to 
remove fragility from a fragile region.  Increased resolution from SNP mapping in the CO assay, 
or a greater number of integrations in the S2 cell assay, should help identify the relevant 
characteristics.  To introduce fragility, one would create a de novo CFS – not derived from any 
specific Drosophila sequence, but having the characteristics of a minimal fragile region.  This site 
could then be inserted into specific genomic locations using ΦC31-mediated integration and 
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tested for fragility with my crossover assay (BATEMAN et al. 2006).  Alternatively, adding a 
selectable marker and 1-2 kb of specific Drosophila sequence to either end of the construct and 
transfecting it into S2 cells would establish a line of cells with the new CFS stably integrated in a 
targeted manner, which could in turn be used to test for fragility in the integration assay (RONG 
and GOLIC 2000). Experiments in which a section of human FRA3B was inserted in ectopic 
regions of the genome – and found to maintain fragility – suggest that this type of experiment 
would be feasible with a de novo CFS (RAGLAND et al. 2008).   
A complementary approach to these would be the ablation of fragility in known CFSs.  
Here, the approach will depend on the characteristic of fragility one wishes to abolish.  For 
example, replication timing and distance to origins could be disrupted by mutation of nearby 
origins.  Alternatively, deletions flanking the CFS could be used to bring origins closer.  Direct 
manipulation of the sequence, such as removal of a minimal fragile region, could be used to test 
the contribution of sequence to fragility.  Indeed, it has been found that such deletions in CFSs 
can reduce fragility (ARLT et al. 2002).  However, such deletions do not always result in a 
complete reduction in fragility, and sometimes do not result in a reduction of fragility at all 
(CORBIN et al. 2002; DURKIN et al. 2008) .  Furthermore, it has been pointed out that simply 
deleting sequence conflates the contribution of primary sequence and origin distance; taking out 
putative fragile sequence could also result in a reduction of the distance between origins, thereby 
making it easier for the cell to complete replication of the region before mitosis (LETESSIER et al. 
2011).  Therefore, I propose that future experiments that seek to test the influence of fragile 
sequence replace putative fragile sequence with a non-fragile sequence of equal length.  Such a 
replacement could be accomplished through gene targeting by homologous recombination (RONG 
and GOLIC 2000).   
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Useful modifications to assays 
Both assays described here are extremely versatile, and have the potential for applications 
beyond the detection and analysis of Drosophila CFSs.  For example, the cell-based integration 
assay is relatively easy to port to human cell culture.  Modifications may be required for the type 
of selection used, but the main scheme of transfecting cells with a selectable construct, with or 
without aphidicolin, and using paired-end HTS to identify integration sites, should work well in 
human cells.  Others have used integration-based approaches to clone CFSs of known location, 
but have done so on a relatively small scale, analyzing only a single fragile site at a time 
(MISHMAR et al. 1998; RASSOOL et al. 1996).  The whole-genome HTS integrated into my 
insertion assay allows for a much broader scope, while retaining a high resolution. 
The ability to study human CFSs with a high throughput will become increasingly 
important.  Seventy-five of the eighty-eight human CFSs have not been studied at the molecular 
level; my integration assay could be used to provide an in-depth characterization of such sites 
(LUKUSA and FRYNS 2008).  In addition, even among the thirteen CFSs that have been 
molecularly characterized, studies have indicated that the differences in CFS expression between 
individuals, or between different tissues, are substantial enough to warrant further study 
(DENISON et al. 2003; LETESSIER et al. 2011).  Much of the study of CFSs has taken place in 
lymphocytes, so many tissues remain to be studied.  Using my integration assay in human cells 
provides an efficient means of examining different tissues and patient samples. 
There are opportunities to expand the scope of damage detected by my assays, as well.  
The integration assay was used here to identify insertions into sites of both endogenous damage 
and damage induced by aphidicolin.  However, the exogenous DNA damaging agents examined 
by the assay need not be limited to aphidicolin.  For example, one could treat cells with ionizing 
radiation, and locate the resulting DSBs at a very high resolution.  To my knowledge, there is 
little understood about which genomic regions, if any, that might be susceptible to ionizing 
radiation; the assay I have developed provides the opportunity to investigate the issue.  A 
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complementary approach might be to treat flies with IR, and use the crossover assay to ascertain 
the location of breaks. 
 
Conclusion 
My discovery of CFSs in Drosophila has identified an important link in the evolutionary 
conservation of CFSs, and added to a growing body of evidence that connects BLM and fragile 
sites.  In addition, I developed two useful assays, and laid the groundwork for future studies.  The 
SNP mapping of mitotic crossovers – reciprocal and otherwise – and the ability to take the HTS 
integration assay in new directions will be important steps to determining the causes of genome 
instability.  As noted above, these future experiments need not be limited to Drosophila; studies 
of various human populations and tissues can benefit from this work, as well as examinations of 
DNA damaging agents.  In total, this work has contributed to a growing body of knowledge on 
chromosome fragility, and puts us in an excellent position to learn even more. 
 
 
 
 
 
 
 
 
Appendix Chapter 
Transcription Initiation from Within P Elements Generates Hypomorphic Mutations in 
Drosophila melanogaster 
 
Preface 
The following is a manuscript written by myself and Dr. Jeff Sekelsky, which was submitted to 
the journal Genetics as a Note.  While not directly related to CFSs, this work speaks to the effect 
that DNA insertions can have on their local genomic environment.  At the time of the submission 
of this dissertation, the manuscript is under review at Genetics. 
 
Results & Discussion 
Genetically engineered P elements have been used as tools for experimental manipulation 
of the Drosophila genome (BELLEN et al. 2004; THIBAULT et al. 2004).  These elements tend to 
insert near transcription start sites, frequently resulting in hypomorphic mutations (SPRADLING et 
al. 1995).  This result is sometimes surprising, as insertions within early exons might be expected 
to produce null mutations rather than hypomorphs.  Here, we report that transcription initiation 
from within a P element may be responsible for some mutations being hypomorphic rather than 
null.   
We first observed this phenomenon in a P insertion allele of nbs (Figure 5.1A).  The 
nbsEY15506 allele contains a 10.9 kb P{EPgy2} element inserted into the coding sequence in the 
second exon.  Although the insertion separates two conserved domains, it creates not a null allele, 
but a hypomorphic, separation-of-function allele.  The nbsSM9 derivative has an internal deletion 
of about 7 kb of this P element (Figure 5.1B), but retains the hypomorphic nature of nbsEY15506.  
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We previously reported that the hypomorphic character of nbsSM9 was due, at least in part, to 
transcription that initiated from within the P element (Figure 5.1C) (MUKHERJEE et al. 2009).  
Using 5’ RACE, we found that transcription initiated in the region downstream of the 3’ end of 
the white (w) gene carried on the P element – a region that is located 3’ to the endogenous w 
locus, but is not part of the annotated w gene span.  In addition, we detected that three introns, 
with canonical splice donor and acceptor sequences, had been spliced out (Figure 5.1C, D).  Two 
of these introns are located in the region downstream of w, but the third is within the P element 5’ 
end, which is transcribed in the opposite direction to P transposase.  The terminal three bp of the 
P end form an in-frame start codon.  Results from our assays suggested that retention of some 
NBS functions was due to production of a protein lacking the N-terminal FHA domain. 
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Figure 5.1.  A cryptic transcript initiates from within a P element in nbs.  (A) The 
nbsEY15506 allele has a 10.9 kb P{EPgy2} element inserted into the 2nd exon.  The P element is 
oriented with the 5’ end nearest the 3’ end of the nbs coding region.  Lighter-colored regions 
indicate UTRs.  (B) The P element contains the w gene and its surrounding endogenous 
regions (red) oriented toward the 5’ P end (black), as well as the yellow gene (brown) and a S. 
cerevisiae UAS promoter (gray arrow).  The nbsSM9 allele is an internally deleted version of 
nbsEY15506 that retains about 3 kb of the P element.  (C) The cryptic transcript detected by the 
5´ RACE System for Rapid Amplification of cDNA Ends, Version 2.0 (Invitrogen; catalog 
#18374-058).  Transcription initiation appears to initiate in the region downstream of w.   
Three introns are spliced out in adult RNA samples.  (D) The sequence of the cryptic 
transcript is represented in capital letters; lowercase letters represent sequences present in the 
DNA that are spliced out in the transcript.  Red letters, the region downstream of w; gray 
letters, P element backbone sequence; black letters, the 5’ P end.   
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The nbsSM9 allele is unusual in that the P element is inserted into coding sequences.  To 
determine whether insertions in other regions can also produce hypomorphic alleles due to 
transcription from a P element, we analyzed an insertion into the 5’ untranslated region (UTR) of 
the Slbp gene (Figure 5.2A).  This insertion creates a hypomorphic allele (SULLIVAN et al. 2001).  
The structure of the P{EP} element in this allele differs from that of the P{EPgy2}element we 
analyzed in nbs, but in both cases the element is inserted so that the w gene is transcribed in the 
same direction as the gene into which the P element is inserted (Figure 5.2B).  SULLIVAN et al. 
(2001) carried out a P excision screen and generated hypomorphic and null alleles, both caused 
by internal deletions within the P element, without deletion of Slbp sequence. Deletions that 
removed the region downstream of the w gene, such as the null allele Slbp15, do not produce Slbp 
transcript.  In contrast, the hypomorphic allele Slbp10, which lost much of the P element but 
retained the region downstream of w, produces both Slbp transcript and SLBP protein.   
 
Figure 5.2.  A similar cryptic transcript initiates from within a P element in Slbp.  (A) 
The SlbpEP3182 allele has an 8 kb P{EP} element inserted in the 5’ UTR.  The P element is 
oriented with the 5’ end nearest the Slbp coding region.  (B) The P{EP} element contains the 
w gene and its surrounding endogenous regions (red) oriented toward the 5’ P end (black); 
other features are as described by Rørth (1996).  Slbp10 has a deletion from 2,029-6,266.  (C) 
The cryptic transcript was detected by using a combination of PCR and the 5´ RACE System.  
Our PCR did not facilitate the detection of the 5’ end of the transcript, but the position of the 
upstream primer is consistent with transcription initiation that occurs in the region 
downstream of w.  Three cryptic introns are spliced out in adult RNA samples; a larval 
sample did not have the intron in the 5’ P end spliced out.
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We performed PCR on cDNA from Slbp10/TM6B adults and 2nd instar larvae, and found 
that there is also transcription from the region downstream of w in this P{EP} element.  In adults, 
the sequence and splice sites are identical to those we detected in nbsSM9 (Figure 5.1D; Figure 
5.2C).  Intriguingly, removal of the intron in the P end was not detected in cDNA isolated from 
larvae, raising the possibility that splicing of the intra-P transcript may be regulated by tissue 
and/or developmental timing. 
These findings provide insight into the nature of hypomorphic alleles that arise from 
certain transposable element insertions.  For example, there is no guarantee that transcription 
from within the transposable element will match the expression pattern of the gene’s native 
promoter.  If this is the case, altered expression may result in different severities, potentially 
ranging from wild-type function in some tissues to complete absence of function in other tissues. 
Features of these cryptic transcripts that affect translation efficiency may play a role in 
the reduced function as well.  While Slbp10 mutants produce SLBP protein, they do so at reduced 
levels (SULLIVAN et al. 2001).  This may be due to characteristics of the cryptic transcript.  
Among the exons on the P-element-Slbp transcript, the exon in which translation begins – a 
fusion of the 5’ P end and the remaining sequence of the 5’ UTR and start of the coding region of 
Slbp – is the only exon that does not contain a short open reading frame.  This suggests that 
translation can successfully take place only when ribosomes bind to that key exon, as binding to 
the upstream exons would lead to premature termination of translation, and potentially to 
nonsense-mediated decay (NMD) (GATFIELD et al. 2003; PELTZ et al. 1993).  This feature may 
contribute to the hypomorphic character of some mutants with intra-P transcription: even if 
transcript were being produced at the normal rate, transcript degradation may ensure that not all 
transcripts would survive to be translated, leading to a reduced level of protein.  The cryptic 
transcript of nbsSM9 does not share this characteristic.  Rather, we found that levels of nbsSM9 
transcript appeared to be similar to that of wild-type (MUKHERJEE et al. 2009).  This suggests that 
NMD may not be involved in reducing the levels of nbs transcript.  This is curious, as the P 
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elements in Slbp10 and nbsSM9 have identical sequence in the region of the cryptic transcript.  This 
suggests that the stability of these transcripts is affected by additional factors that are not 
immediately apparent. 
The position and orientation of a P element insertion may have additional ramifications 
for mutagenesis.  Insertions in introns may invoke alternative splicing of the native transcript, 
possibly resulting in impaired functionality of the transcript or protein.  Additionally, it may be 
that insertions that take place in a gene span, but which transcribe the region downstream of w in 
the opposite direction as the gene, may produce antisense RNA.  These transcripts could initiate 
RNA interference of the native transcript, providing another means of producing a hypomorph.   
The region from which intra-P transcription appears to initiate corresponds to the 
genomic location X:2,683,995..2,684,631, directly upstream of the gene CG32795 (Drosophila 
melanogaster genome release 5.34) (TWEEDIE et al. 2009).  However, stable transcripts from this 
region have not been detected.  Transcripts in this region are absent from most modENCODE 
genome browser RNA expression profiling tracks, except in those of immunoprecipitation of 
Argonaute-1 or 2 in S2 cells (CELNIKER et al. 2009).  It may be that this region does undergo 
transcription, but as no translation follows, the transcripts are not stable or are degraded.  This 
phenomenon may be analogous to that of cryptic unstable transcripts observed in budding yeast 
(WYERS et al. 2005).   
The w gene is a common marker in engineered transposable elements in Drosophila. 
Transcription initiation from within these elements is likely to contribute to the hypomorphic 
mutations generated by many of these insertion alleles. 
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